Bibliography of Prof. Dr. med. Günter K. Stalla · 423. Boeckel JN, Palapies L, Klotsche J, Zeller...

1

Bibliography of Prof. Dr. med. Günter K. Stalla

425. Albani A, Perez-Rivas LG, Dimopoulou C, Zopp S, Colon-Bolea P, Roeber S, Honegger J, Flitsch J,

Rachinger W, Buchfelder M, Stalla GK, Herms J, Reincke M, Theodoropoulou M. The USP8 mutational

status may predict long-term remission in patients with Cushing’s disease. Clin Endocrinol 2018; Epub

ahead of print

424. Auer MK, Stalla GK, Kopczak A. In reply. Dtsch Arztebl Int 2018; 115(18):325.

423. Boeckel JN, Palapies L, Klotsche J, Zeller T, von Jensen B, Perret MF, Kleinhaus SL, Pieper L, TZikas

S, Leistner D, Bickel C, Stalla GK, Lehnert H, Lindahl B, Wittchen HU, Silber S, Baldus S, Maerz W,

Dimmeler S, Blankenberg S, Münzel T, Zeiher AM, Keller T. Adjusted troponin I for improved

evaluation of patients with chest pain. Sci Rep 2018; 8(1):8087.

422. Auer MK, Fuss J, Nieder TO, Briken P, Biedermann SV, Stalla GK, Beckmann MW, Hildebrandt T.

Desire to have children among transgender people in Germany: a cross-sectional multi-center study. J

Sex Med 2018; 15(5):757-67.

421. Fuertes M, Sapochnik M, Tedesco L, Senin S, Attorresi A, Ajler P, Carrizo G, Cervio A, Sevlever G,

Bonfiglio JJ, Stalla GK, Arzt E. Protein stabilization by RSUME accounts for PTTG pituitary tumor

abundance and oncogenicity. Endocr Relat Cancer 2018; 25(6):665-76.

420. Valassi E, Feelders R, Maiter D, Chanson P, Yaneva M, Reincke M, Krsek M, Toth M, Webb SM,

Santos A, Paiva I, Komerdus I, Droste M, Tabarin A, Strasburger CJ, Franz H, Trainer PJ, Newell-Price

J, Wass JA, Papakokkinou E, Ragnarsson O, ERCUSYN Study Group. Worse health-related quality of

life at long-term follow-up in patients with Cushing’s disease than patients with cortisol producing

adenoma. Data from the ERCUSYN. Clin Endocrinol 2018; (Epu ahead of print)

419. Aristizabal Prada ET, Heinzle V, Knösel T, Nölting S, Spoettl G, Maurer J, Spitzweg C, Angele M,

Schmidt N, Beuschlein F, Stalla GK, Blaser R, Kuhn KA, Auernhammer CJ. Tropomyosin receptor

kinase: a novel target in screened neuroendocrine tumors. Endocr Relat Cancer 2018; 25(5):547-60.

418. Athanasoulia-Kaspar AP, Popp KH, Stalla GK. Neuropsychiatric and metabolic aspects of dopaminergic

therapy: perspectives from an endocrinologist and a psychiatrist. Endocr Connect 2018; 7(2):R88-R94.

417. Auer MK, Ebert T, Pietzner M, Defreyne J, Fuss J, Stalla GK, T’Sjoen G. Effects of sex hormone

treatment on the metabolic syndrome in transgender individuals: focus on metabolic cytokines. J Clin

Endocrinol Metab 2018; 103(2):790-802.

416. Woost L, Bazin PL, Taubert M, Trampel R, Tardif CL, Garthe A, Kempermann G, Renner U, Stalla G,

Ott DVM, Rjosk V, Obrig H, Villringer A, Roggenhofer E, Klein TA. Physical exercise and spatial

training: a longitudinal study of effects on cognition, growth factors, and hippocampal plasticity. Sci Rep

2018; 8(1):4239.

415. Auer MK, Stieg MR, Crispin A, Sievers C, Stalla GK, Kopczak A. Primary empty sella syndrome and

the prevalence of hormonal dysregulation. Dtsch Arztebl Int 2018; 115(7):99-105.

414. Perez-Rivas LG, Theodoropoulou M, Puar TH, Fazel J, Stieg MR, Ferrau F, Assie G, Gadelha MR,

Deutschbein T, Fragoso MC, Kusters B, Saeger W, Honegger J, Buchfelder M, Korbonits M, Bertherat J,

Stalla GK, Hermus A, Beuschlein F, Reincke M. Somatic USP8 mutations are frequent events in

corticotroph tumor progression causing Nelson’s tumor. Eur J Endocrinol 2018; 178(1):59-65.

413. Kann PH, Bergmann S, Bidlingmaier M, Dimopoulou C, Pedersen BT, Stalla GK, Weber MM, Meckes-

Färber S. Design oft he growth hormone deficiency and efficacy of treatment (GET) score and non-

interventional proof of concept study. BMC Endocr Disord 2018; 18(1):10.

412. Kische H, Pieper L, Venz J, Klotsche J, März W, Koch-Gromus U, Pittrow D, Lehnert H, Silber S, Stalla

GK, Zeiher AM, Wittchen HU, Haring R. Longitudinal change instead of baseline testosterone predicts

depressive symptoms. Psychoneuroendocrinology 2017; 89:7-12.

411. Gebert D, Auer MK, Stieg MR, Freitag MT, Lahne M, Fuss J, Schilbach K, Schopohl J, Stalla GK,

Kopczak A. De-masking oxytocin-deficiency in craniopharyngioma and assessing ist link with affective

function. Psychoneuroendocrinology 2017; 88:61-9.

410. Petersenn S, Christ-Crain M, Droste M, Finke R, Flitsch J, Kreitschmann-Andermahr I, Luger A,

Schopohl J, Stalla GK. Diagnostics and treatment of acromegaly: Necessity for targeted monitoring of

comorbidities. Internist (Berl) 2017; 58(11):1171-82.

409. Schmidt N, Schmidt B, Dressel A, Gergei I, Klotsche J, Pieper L, Scharnagl H, Kleber ME, März W,

Lehnert H, Pittrow D, Stalla G, Wittchen HU, Grammer TB. Familial hypercholesterolemia in primary

care in Germany. Diabetes and cardiovascular risk evaluation; Targets and essential data for commitment

of treatment (DETCT) study. Atherosclerosis 2017; 266:24-30.

408. Schöfl C, Petroff D, Tönjes A, Grussendorf M, Droste M, Stalla G, Jaursch-Hancke C, Störmann S,

Schopohl J. Incidence of myocardial infarction and stroke in acromegaly patients: results from the

German Acromegaly Registry. Pituitary 2017; 20(6):635-42.

407. Dimopoulou C, Stalla GK. Testosterone deficiency and dementia. Dtsch Med Wochenschr 2017;

142(15):1102-5.

2

406. Petrossians P, Daly AF, Natchev E, Maione L, Blijdorp K, Sahnoun Fathallah M, Auriemma R, Diallo

AM, Hulting AL, Ferone D, Hana V, Filipponi S, Sievers C, Nogueira C, Fajardo Montanana C,

Carvalho DMC, Hana V, Stalla GK, Jaffrain-Rea ML, Delemer B, Colao AAL, Brue T, Neggers

SJCMM, Zacharieva S, Chanson P, Beckers A. Acromegaly at diagnosis in 3173 patients from the Liege

Acromegaly Survey (LAS) database. Endocr Relat Cancer 2017; 24(10):505-18.

405. Streuli R, Krull I, Brändle M, Kolb W, Stalla G, Theodoropoulou M, Enzler-Tschudy A, Bilz S. A rare

case of an ACTH/CRH co-secreting midgut neuroendocrine tumor mimicking Cushing’s disease.

Endocrinol Diabetes Metab Case Rep 2017. Doi: 10.1530/EDM-17-0058. eCollection.

404. Keller T, Boeckel JN, Groß S, Klotsche J, Palapies L, Leistner D, Pieper L, Stalla GK, Lehnert H, Silber

S, Pittrow D, Maerz W, Dörr M, Wittchen HU, Baumeister SE, Völker U, Felix SB, Dimmeler S, Zeiher

AM. Improved risk stratification in prevention by use of a panel of selected circulating microRNAs. Sci

Rep 2017; 7(1):4511.

403. Kopczak A, Schumacher AM, Nischwitz S, Kümpfel T, Stalla GK, Auer M. GAD antibody-associated

limbic encephalitis in a young woman with APECED. Endocrinol Diabetes Metab Case Rep 2017. Doi:

10.1530/EDM-17-0010. eCollection.

402. Di Dalmazi G, Quinkler M, Deutschbein T, Prehn C, Rayes N, Kroiss M, Berr CM, Stalla GK, Fassnacht

M, Adamski J, Reincke M, Beuschlein F. Cortisol-related metabolic alterations assessed by mass

spectrometry assay in patients with Cushing’s syndrome. Eur J Endocrinol 2017; 177(2):227-37.

401. La Marca-Ghaemmaghami P, Dainese SM, Stalla G, Haller M, Zimmermann R, Ehlert U. Second-

trimester amniotic fluid corticotropin-releasing hormone and urocortin in relation to maternal stress and

fetal growth in human pregnancy. Stress 2017; 20(3):231-40.

400. Berr CM, Stieg MR, Deutschbein T, Quinkler M, Schmidmaier R, Osswald A, Reisch N, Ritzel K,

Dimopoulou C, Fazel J, Hahner S, Stalla GK, Beuschlein F, Reincke M. Persistence of myopathy in

Cushing’s syndrome: evaluation oft he German Cushing’s Registry. Eur J Endocrinol 2017; 176(6):737-

46.

399. Geraedts VJ, Andela CD, Stalla GK, Pereira AM, van Furth WR, Sievers C, Biermasz NR. Predictors of

quality of life in acromegaly: no consensus on biochemical parameters. Front Endocrinol (Lausanne)

2017;8:40.

398. Stieg MR, Renner U, Stalla GK, Kopczak A. Advances in understanding hypopituitarism. F1000Res

2017;6:178.

397. Kann PH, Bergmann S, Stalla GK, Dimopoulou C, Weber MM, Pedersen BT, Meckes-Ferber S. Gender-,

age- and time-dependent dosing of growth hormone in adults - real-world data from a decade of clinical

practice in Germany. Gynecol Endocrinol 2017;5:1-6.

396. Renner U, Sapochnik M, Lucia K, Stalla GK, Arzt E. Intrahypophyseal immune-endocrine interactions:

Endocrine integration of the inflammatory inputs. Front Horm Res 2017;48:37-47.

395. Auer MK, Liedl A, Fuss J, Nieder T, Briken P, Stalla GK, Hildebrandt T, Biedermann SV, Sievers C.

High impact of sleeping problems on quality of life in transgender individuals: A cross-sectional

multicenter study. PLoS One 2017;12(2):e0171640.

394. Franck SE, Korevaar T, Petrossians P, Daly AF, Chanson P, Jaffrian-Rea M, Brue T, Stalla GK,

Carvalho D, Colao AA, Hana V, Delemer B, Montanana CF, Van der Lely AJ, Beckers A, Neggers SJ. A

multivariable prediction model for pegvisomant dosing monotherapy and in combination with long-

acting somatostatin analogues. Eur J Endocrinol 2017;176(4):421-30.

393. Dimopoulou C, Leistner SM, Ising M, Schneider HJ, Schopohl J, Rutz S, Kosilek R, Frohner R, Stalla

GK, Sievers C. Body image perception in acromegaly is not associated with objective acromegaly

changes, but depends on depressive symptoms. Neuroendocrinology 2017;105(2):115-22.

392. Murray RD, Ekman B, Uddin S, Marelli C, Quinkler M, Zelissen PM, the EU-AIR Investigators.

Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data

from the EU-AIR. Clin Endocrinol (Oxf) 2017;86(3):340-6.

391. Sapochnik M, Haedo MR, Fuertes M, Ajler P, Carrizo G, Cervio A, Seviever G, Stalla GK, Arzt E.

Autocrine IL-6 mediates pituitary tumor senescence. Oncotarget 2016;8(3):4690-702.

390. Ciato D, Mumbach AG, Paez-Pereda M, Stalla GK. Currently used and investigational drugs for

Cushing’s disease. Expert Opin Investig Drugs 2016; 26(1):75-84.

389. Auer MK, Cecil A, Roepke Y, Bultynck C, Pas C, Fuss J, Prehn C, Wang-Sattler R, Adamski J, Stalla

GK, T’Sjoen G. 12-months metabolic changes among gender dysphoric individuals under cross-sex

hormone treatment: a targeted metabolomics study. Sci Rep 2016;6:37005.

388. Sack M, Lenz JN, Jakovcevski M, Biedermann SV, Falvan-Melgoza C, Deussing J, Bielohuby M,

Bidlingmaier M, Pfister F, Stalla GK, Sartorius A, Gass P, Weber-Fahr W, Fuss J, Auer MK. Early

effects of a high-caloric diet and physical exercise on brain volumetry and behavior: a combined MRI

and histology study in mice. Brain Imaging Behav 2016; 11(5):1385-96.

3

387. Wu Y, Tedesco L, Schlitter AM, Garcia JM, Esposito I, Auernhammer CJ, Theodoropoulou M, Arzt E,

Renner U, Stalla G. RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine

tumors. Oncotarget 2016;7(36):57878-93.

386. Auer MK, Stalla GK, Stieg MR. Investigating the role of cortisol and growth hormone in fatty liver

development: fatty liver index in patients with pituitary adenomas. Pituitary 2016; 19(5):461-71.

385. Krewer C, Schneider M, Schneider HJ, Kreitschmann-Andermahr I, Buchfelder M, Faust M, Berg C,

Wallaschowfski H, Renner C, Uhl E, Koenig E, Jordan M, Stalla GK, Kopczak A. Neuroendocrine

disturbances one to five or more years after traumatic brain injury and aneurysmal subarachnoid

hemorrhage: data from the German database on hypopituitarism. J Neurotrauma 2016; 33(16):1544-53.

384. Auer MK, Stieg MR, Hoffmann J, Stalla GK. Is insulin-like-growth-factor-I a good marker for treatment

adherence in growth-hormone deficiency in adulthood? Clin Endocrinol (Oxf); 84(6):862-9.

383. Auer MK, Hellweg R, Briken P, Stalla GK, T’Sojen GG, Fuss J. Serum brain-derived neurotrophic factor

(BDNF) is not regulated by testosterone in transmen. Biol Sex Diff 2016; 7:1.

382. Kopczak A, Krewer C, Schneider M, Kreitschmann-Andermahr I, Schneider HJ, Stalla GK. The

development of neuroendocrine disturbances over time – longitudinal findings in patients after traumatic

brain injury and subarachnoid hemorrhage. Int J Mol Sci 2015; 17(1). pii E2.

381. Lelle M, Kaloyanova S, Freidel C, Theodoropoulou M, Musheev M, Niehrs C, Stalla G, Peneva K.

Octreotide-mediated tumor-targeted drug delivery via cleavable doxorubicin-peptide conjugate. Mol

Pharm 2015; 12(12):4290-300.

380. Petroff D, Tönjes A, Grussendorf M, Droste M, Dimopoulou C, Stalla G, Jaursch-Hanke C, Mai M,

Schopohl J, Schöfl C. The incidence of cancer amongst acromegaly patients: results from the German

Acromegaly Registry. J Clin Endocrinol Metab 2015; 100(10):3894-902.

379. Sievers C, Baur DM, Schwanke A, Buchfelder M, Droste M, Mann K, Stalla GK. Prediction of therapy

response in acromegalic patients under pegvisonmant therapy within the German ACROSTUDY cohort.

Pituitary 2015;18(6):916-23.

378. Rostomyan L, Daly AF, Petrossians P, Nachev E, Lila AR, Lecoq AL, et al. Clinical and genetic

characterization of pituitary gigantism: an international collaborative study in 208 patients. Endocr Relat

Cancer 2015;22(5):745-57.

377. Honegger J, Buchfelder M, Schlaffer S, Droste M, Werner S, Strasburger C, Störmann S, Schopohl J,

Kacheva S, Deutschbein T, Stalla G, Flitsch J, Milian M, Petersenn S; Ulf Elbelt on behalf of the

Pituitary Working Group of the German Society of Endocrinology. Treatment of primary hypophysitis in

Germany. J Clin Endocrinol Metab 2015;100(9):3460-9.

376. Reincke M, Ritzel K, Oßwald A, Berr C, Stalla G, Hallfeldt K, Reisch N, Schopohl J, Beuschlein F. A

critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing’s syndrome. Eur J

Endocrinol 2015;173(4):M23-32.

375. Perez-Rivas LG, Theodoropoulou M, Ferrau F, Nusser C, Kawaguchi K, Stratakis CA, Faucz FR,

Wildemberg LE, Assie G, Beschorner R, Dimopoulou C, Buchfelder M, Popovic V, Berr CM, Toth M,

Ardisasmita AI, Honegger J, Bertherat J, Gadelha MR, Beuschlein F, Stalla G, Komada M, Korbonits M,

Reincke M. The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing

Cushing’s disease. J Clin Endocrinol Metab 2015;100(7):E997-1004.

374. Kopczak A, Kloiber S, Auer MK, Grabe HJ, Stalla GK, Sievers C. Letter to the editor.

Psychoneuroendocrinology 2015;57:111-2.

373. Kopczak A, Stalla GK, Uhr M, Lucae S, Hennings J, Ising M, Holsboer F, Kloiber S. IGF-I in major

depression and antidepressant treatment response. Eur Neuropsychopharmacol 2015;25(6):864-72.

372. Dimopoulou C, Geraedts V, Stalla GK, Sievers C. Neuropsychiatric and cardiometabolic comorbidities

in patients with previously diagnosed Cushing’s disease: a longitudinal observational study. BMJ Open

2015;5(3):e006134.

371. Leistner SM, Klotsche J, Dimopoulou C, Athanasoulia AP, Roemmler-Zehrer J, Pieper L, Schopohl J,

Wittchen HU, Stalla GK, Fulda S, Sievers C. Reduced sleep quality and depression associate with

decreased quality of life in patients with pituitary adenomas. Eur J Endocrinol 2015;172(6):733-43.

370. Kao CY, Stalla G, Stalla J, Wotjak CT, Anderzhanova E. Norepinephrine and corticosterone in the

medial prefrontal cortex and hippocampus predict PTSD-like symptoms in mice. Eur J Neurosci

2015;41(9):1139-48.

369. Schöfl C, Grussendorf M, Honegger J, Tönjes A, Thyroke-Gronostay D, Mayr B, Schopohl J:

participants of the German Acromegaly Register. Failure to achieve disease control in acromegaly: cause

analysis by a registry-based survey. Eur J Endocrinol 2015;172(6):351-6.

368. Riebold M, Kozany C, Freiburger L, Sattler M, Buchfelder M, Hausch F, Stalla GK, Paez-Pereda M. A

C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of

Cushing’s disease. Nat Med 2015;21(3):276-80.

4

367. Geraedts VJ, Dimopoulou C, Auer M, Schopohl J, Stalla GK, Sievers C. Health outcome in acromegaly:

depression and anxiety are promising targets for improving reduced quality of life. Front Endocrinol

(Lausanne) 2015;5:229.

366. Petersenn S, Beckers A, Ferone D, Van der Lely AJ, Bollerslev J, Boscaro M, Brue T, Bruzzi P,

Casanueva FF, Chanson P, Colao AA, Reincke M, Stalla GK, Tsagarakis S. Therapy of endocrine

disease: Outcomes in patients with Cushing’s disease undergoing transsphenoidal surgery: systematic

review assessing criteria used to define remission and recurrence. Eur J Endocrinol 2015;172(6):R227-

39.

365. Labeur M, Wölfel B, Stalla J, Stalla GK. TMEFF2 is an endogenous inhibitor of the CRH signal

transduction pathway. J Mol Endocrinol 2015;54(1):51-63.

364. Auer MK, Sack M, Lenz JN, Jacovcevski M, Biedermann SV, Falfan-Melgoza C, Deussing J, Steinle J,

Bielohuby M, Bidlingmaier M, Pfister F, Stalla GK, Ende G, Weber-Fahr W, Fuss J, Gass P. Effect of a

high-caloric diet and physical exercise on brain metabolite levels: a combined proton MRS and histologic

study. J Cereb Blood Flow Metab 2015;35(4):554-64.

363. Stieg MR, Sievers C, Farr O, Stalla GK, Mantzoros CS. Leptin: a hormone linking activation of

neuroendocrine axes with neuropathology. Psychoneuroendocrinology 2015;51C:47-57.

362. Gerez J, Tedesco L, Bonfiglio JJ, Fuertes M, Barontini M, Silberstein S, Wu Y, Renner U, Paez-Pereda

M, Holsboer F, Stalla GK, Arzt E. RSUME inhibits VHL and regulates its tumor suppressor function.

Oncogene 2015;34(37):4855-66.

361. Fuss J, Hellweg R, Van Caenegem E, Briken P, Stalla GK, T’Sojen G, Auer MK. Cross-sex hormone

treatment in male-to-female transsexual persons reduces serum brain-derived neurotrophic factor

(BDNF). Eur Neuropsychopharmacol 2015;25(1):95-9.

360. Schöfl C, Honegger J, Droste M, Grussendorf M, Finke R, Plöckinger U, Berg C, Willenberg HS,

Lammert A, Klingmüller D, Jaursch-Hancke C, Tönjes A, Schneidewind S, Flitsch J, Bullmann C,

Dimopoulou C, Stalla G, Mayr B, Hoeppner W, Schopohl J. Frequency of AIP gene mutations in young

patients with acromegaly: a registry-based study. J Clin Endocrinol Metab 2014;99(12):E2789-93.

359. Roemmler-Zehrer J, Geigenberger V, Störmann S, Ising M, Pfister H, Sievers C, Stalla GK, Schopohl J.

Specific behaviour, mood and personality traits may contribute to obesity in patients with

craniopharyngioma. Clin Endocrinol (Oxf) 2015;82(1):106-14.

358. Yaron M, Renner U, Gilad S, Stalla GK, Stern N, Greenman Y. KISS1 receptor is preferentially

expressed in clinically non-functioning pituitary tumors. Pituitary 2015;18(3):306-11.

357. Auer MK, Fuss J, Höhne N, Stalla GK, Sievers C. Transgender transitioning and change of self-reported

sexual orientation. PLoS ONE 2014;9(10):e110016.

356. Wu Y, Lucia K, Lange M, Kuhlen D, Stalla GK, Renner U. Hypoxia inducible factor-1 is involved in

growth factor, glucocorticoid and hypoxia mediated regulation of vascular endothelial growth factor-A in

human meningiomas. J Neurooncol 2014;119(2):263-73.

355. Dimopoulou C, Schopohl J, Rachinger W, Buchfelder M, Honegger J, Reincke M, Stalla GK. Long-term

remission and recurrence rates after first and second transsphenoidal surgery for cushing's disease: Care

reality in the munich metropolitan region. Eur J Endocrinol 2014;170(2):283-92.

354. Kopczak A, Kilimann I, Von Rosen F, Krewer C, Schneider HJ, Stalla GK, Schneider M. Screening for

hypopituitarism in 509 patients with traumatic brain injury or subarachnoid hemorrhage. J Neurotrauma

2014;31(1):99-107.

353. Kopczak A, Renner U, Stalla GK. Advances in understanding pituitary tumors. F1000Prime Reports

2014;6.

352. Auer M, Stalla GK. Persistence of postmenopausal flushes. is there a role for the pituitary?

Gynakologische Praxis 2014;38(4):641-5.

351. Dimopoulou C, Athanasoulia AP, Hanisch E, Held S, Sprenger T, Toelle TR, Roemmler-Zehrer J,

Schopohl J, Stalla GK, Sievers C. Clinical characteristics of pain in patients with pituitary adenomas. Eur

J Endocrinol 2014;171(5):581-91.

350. Leistner DM, Klotsche J, Palm S, Pieper L, Stalla GK, Lehnert H, Silber S, März W, Wittchen H-, Zeiher

AM. Prognostic value of reported chest pain for cardiovascular risk stratification in primary care. Eur J

Prev Cardiol 2014;21(6):727-38.

349. Kopczak A, Stalla GK. Neuroendocrine disorders after traumatic brain injury. A review for clinicians.

Tägliche Praxis 2014;55(2):281-91.

348. Roemmler-Zehrer J, Geigenberger V, Störmann S, Losa M, Crippa V, Otto B, Bidlingmaier M,

Dimopoulou C, Stalla GK, Schopohl J. Food intake regulating hormones in adult craniopharyngioma

patients. Eur J Endocrinol 2014;170(4):627-35.

347. Oßwald A, Plomer E, Dimopoulou C, Milian M, Blaser R, Ritzel K, Mickisch A, Knerr F, Stanojevic M,

Hallfeldt K, Schopohl J, Kuhn KA, Stalla G, Beuschlein F, Reincke M. Favorable long-term outcomes of

bilateral adrenalectomy in cushing's disease. Eur J Endocrinol 2014;171(2):209-15.

5

346. Droste M, Domberg J, Buchfelder M, Mann K, Schwanke A, Stalla G, Strasburger CJ. Erratum: Therapy

of acromegalic patients exacerbated by concomitant type 2 diabetes requires higher pegvisomant doses to

normalise IGF1 levels (Eur J Endocrinol (2014) 171:1 (59-68)). Eur J Endocrinol 2014;171(6):X5.

345. Droste M, Domberg J, Buchfelder M, Mann K, Schwanke A, Stalla G, Strasburger CJ. Therapy of

acromegalic patients exacerbated by concomitant type 2 diabetes requires higher pegvisomant doses to

normalise IGF1 levels. Eur J Endocrinol 2014;171(1):59-68.

344. Athanasoulia AP, Stalla GK, Auer MK. Insights into the coexistence of two mutations in the same

LHCGR gene locus causing severe leydig cell hypoplasia. Hormones 2014;13(3):424-9.

343. Stalla GK, Athanasoulia AP, Führer D, Frank-Herrmann P, Oppelt PG, Hauffa BP, Dörr HG. Young

women with ullrich-turner syndrome. recommendations of an expert workshop on the transition to adult

medicine. Gynäkologe 2014;47(2):135-44.

342. Sievers C, Auer MK, Klotsche J, Athanasoulia AP, Schneider HJ, Nauck M, Völzke H, John U, Schulz

A, Freyberger HJ, Friedrich N, Biffar R, Stalla GK, Wallaschofski H, Grabe HJ. IGF-I levels and

depressive disorders: Results from the study of health in pomerania (SHIP). Eur Neuropsychopharmacol

2014;24(6):890-6.

341. Occhi G, Regazzo D, Albiger NM, Ceccato F, Ferasin S, Scanarini M, Denaro L, Cosma C, Plebani M,

Cassarino MF, Mantovani G, Stalla GK, Giraldi FP, Paez-Pareda M, Scaroni C. Activation of the

dopamine receptor type-2 (DRD2) promoter by 9-cis retinoic acid in a cellular model of cushing's disease

mediates the inhibition of cell proliferation and ACTH secretion without a complete corticotroph-to-

melanotroph transdifferentiation. Endocrinology 2014;155(9):3538-49.

340. Kopczak A, Stalla GK. Neuroendocrine disorders after traumatic brain injury. A review for clinicians.

Internist Prax 2014;54(2):323-33.

339. Athanasoulia AP, Sievers C, Uhr M, Ising M, Stalla GK, Schneider HJ. The effect of the ANKK1/DRD2

Taq1A polymorphism on weight changes of dopaminergic treatment in prolactinomas. Pituitary

2014;17(3):240-5.

338. Quinkler M, Beuschlein F, Hahner S, Meyer G, Schöfl C, Stalla GK. Adrenal cortical insufficiency - A life threatening illness with multiple etiologies. Deutsches Ärzteblatt International 2013;110(51-52):882-

8.

337. Kellner M, Salzwedel C, Wortmann V, Urbanowicz T, Boelmans K, Yassouridis A, Stalla GK,

Wiedemann K. No acute suppression of cerebrospinal fluid corticotropin-releasing hormone in man by

cortisol administration. Psychiatry Res 2013;210(2):662-4.

336. Stalla GK, Athanasoulia AP, Führer D, Frank-Herrmann P, Oppelt PG, Hauffa BP, Dörr HG. Transition

of young women with turner syndrome to adult medicine: Current recommendations of an expert

workshop. Monatsschr Kinderheilkd 2013;161(12):1180-6.

335. Fuss J, Biedermann SV, Stalla GK, Auer MK. On the quest for a biomechanism of transsexualism: Is

there a role for BDNF? J Psychiatr Res 2013;47(12):2015-7.

334. Kopp C, Theodorou M, Poullos N, Astner ST, Geinitz H, Stalla GK, Meyer B, Molls M, Nieder C, Grosu

A-. Fractionated stereotactic radiotherapy in the treatment of pituitary adenomas. Strahlenther Onkol

2013;189(11):932-7.

333. Auer MK, Höhne N, Bazarra-Castro MÁ, Pfister H, Fuss J, Stalla GK, Sievers C, Ising M.

Psychopathological profiles in transsexuals and the challenge of their special status among the sexes.

PLoS ONE 2013;8(10).

332. Mayr B, Buslei R, Theodoropoulou M, Stalla GK, Buchfelder M, Schofl C. Molecular and functional

properties of densely and sparsely granulated GH-producing pituitary adenomas. Eur J Endocrinol

2013;169(4):391-400.

331. Auer MK, Fuss J, Stalla GK, Athanasoulia AP. Twenty years of endocrinologic treatment in

transsexualism: Analyzing the role of chromosomal analysis and hormonal profiling in the diagnostic

work-up. Fertil Steril 2013;100(4):1103-10.

330. Auer M, Stalla GK. Persistence of postmenopausal flushes. is there a role for the pituitary? Tägliche

Praxis 2013;54(3):543-7.

329. Auer M, Stalla GK. Persistence of postmenopausal flushes. is there a role for the pituitary? Internist Prax

2013;53(3):517-21.

328. Theodoropoulou M, Stalla GK. Somatostatin receptors: From signaling to clinical practice. Front

Neuroendocrinol 2013;34(3):228-52.

327. Kosilek RP, Schopohl J, Grunke M, Reincke M, Dimopoulou C, Stalla GK, Würtz RP, Lammert A,

Günther M, Schneider HJ. Automatic face classification of cushing's syndrome in women - A novel

screening approach. Exp Clin Endocrinol Diabetes 2013;121(9):561-4.

326. Curic S, Wu Y, Shan B, Schaaf C, Utpadel D, Lange M, Kuhlen D, Perone MJ, Arzt E, Stalla GK,

Renner U. Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas. J Neurooncol

2013;113(3):385-96.

6

325. Auer M, Stalla GK, Athanasoulia AP. Isolated gonadotropic deficiency after multiple concussions in a

professional soccer player. Dtsch Med Wochenschr 2013;138(16):831-3.

324. Athanasoulia AP, Auer M, Riepe FG, Stalla GK. Rare missense P450c17 (CYP17A1) mutation in exon 1

as a cause of 46,XY disorder of sexual development: Implications of breast tissue 'unresponsiveness'

despite adequate estradiol substitution. Sex Develop 2013;7(4):212-5.

323. Leistner DM, Klotsche J, Pieper L, Palm S, Stalla GK, Lehnert H, Silber S, März W, Wittchen H-, Zeiher

AM. Prognostic value of NT-pro-BNP and hs-CRP for risk stratification in primary care: Results from

the population-based DETECT study. Clin Res Cardiol 2013;102(4):259-68.

322. Monteserin-Garcia J, Al-Massadi O, Seoane LM, Alvarez CV, Shan B, Stalla J, Paez-Pereda M,

Casanueva FF, Stalla GK, Theodoropoulou M. Sirt1 inhibits the transcription factor CREB to regulate

pituitary growth hormone synthesis. FASEB Journal 2013;27(4):1561-71.

321. Dimopoulou C, Ising M, Pfister H, Schopohl J, Stalla GK, Sievers C. Increased prevalence of anxiety-

associated personality traits in patients with cushing's disease: A cross-sectional study.

Neuroendocrinology 2013;97(2):139-45.

320. Schneider HJ, Dimopoulou C, Stalla GK, Reincke M, Schopohl J. Discriminatory value of signs and

symptoms in cushing's syndrome revisited: What has changed in 30 years? Clin Endocrinol (Oxf)

2013;78(1):153-4.

319. Labeit AM, Klotsche J, Pieper L, Pittrow D, Einsle F, Stalla GK, Lehnert H, Silber S, Zeiher AM, März

W, Wehling M, Wittchen H-. Changes in the prevalence, treatment and control of hypertension in

germany? A clinical-epidemiological study of 50.000 primary care patients. PLoS ONE 2012;7(12).

318. Athanasoulia AP, Ising M, Pfister H, Mantzoros CS, Stalla GK, Sievers C. Distinct dopaminergic

personality patterns in patients with prolactinomas: A comparison with nonfunctioning pituitary adenoma

patients and age-and gender-matched controls. Neuroendocrinology 2012;96(3):204-11.

317. Bazarra-Castro MÁ, Sievers C, Schwarz HP, Pozza SB-, Stalla GK. Changes in BMI and management of

patients with childhood onset growth hormone deficiency in the transition phase. Experimental and

Clinical Endocrinology and Diabetes 2012;120(9):507-10.

316. Renner C, Hummelsheim H, Kopczak A, Steube D, Schneider HJ, Schneider M, Kreitschmann-

Andermahr I, Jordan M, Uhl E, Stalla GK. The influence of gender on the injury severity, course and

outcome of traumatic brain injury. Brain Injury 2012;26(11):1360-71.

315. Athanasoulia AP, Sievers C, Ising M, Brockhaus AC, Yassouridis A, Stalla GK, Uhr M. Polymorphisms

of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with

PRL adenomas. Eur J Endocrinol 2012;167(3):327-35.

314. Shan B, Schaaf C, Schmidt A, Lucia K, Buchfelder M, Losa M, Kuhlen D, Kreutzer J, Perone MJ, Arzt

E, Stalla GK, Renner U. Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary

adenomas. J Endocrinol 2012;214(3):389-98.

313. Sievers C, Sämann PG, Pfister H, Dimopoulou C, Czisch M, Roemmler J, Schopohl J, Stalla GK, Zihl J.

Cognitive function in acromegaly: Description and brain volumetric correlates. Pituitary 2012;15(3):350-

7.

312. Malysheva O, Wagner U, Wahle M, Wagner U, Stalla GK, Baerwald CGO. Corticotropin releasing

hormone (CRH) response in patients with early rheumatoid arthritis due to polymorphisms in the CRH

gene. Clin Exp Rheumatol 2012;30(3):421-3.

311. Beck-Peccoz P, Minuto F, Leal-Cerro A, Zabransky M, Stalla G. Rationale and design of PATRO adults,

a multicentre, noninterventional study of the long-term efficacy and safety of omnitrope® for the

treatment of adult patients with growth hormone deficiency. Ther Adv Endocrinol Metab 2012;3(3):85-

91.

310. Leistner DM, Klotsche J, Palm S, Pieper L, Stalla GK, Lehnert H, Silber S, März W, Wittchen H-, Zeiher

AM. Resting heart rate as a tool for risk stratification in primary care: Does it provide incremental

prognostic information? Eur J Prev Cardiol 2012;19(2):275-84.

309. Leistner DM, Klotsche J, Pieper L, Stalla GK, Lehnert H, Silber S, März W, Wittchen H-, Zeiher AM.

Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary

prevention. Acta Bioquim Clin Latinoam 2012;46(2):293-302.

308. Shan B, Gerez J, Haedo M, Fuertes M, Theodoropoulou M, Buchfelder M, Losa M, Stalla GK, Arzt E,

Renner U. RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells. Endocr

Relat Cancer 2012;19(1):13-27.

307. Dimopoulou C, Sievers C, Bidlingmaier M, Stalla GK. A case of an acromegalic patient resistant to the

recommended maximum GH receptor antagonist dosage. Hippokratia 2012;16(1):80-2.

306. Friedrich N, Schneider HJ, Haring R, Nauck M, Völzke H, Kroemer HK, Dörr M, Klotsche J, Jung-

Sievers C, Pittrow D, Lehnert H, März W, Pieper L, Wittchen H-, Wallaschofski H, Stalla GK. Improved

prediction of all-cause mortality by a combination of serum total testosterone and insulin-like growth

factor 1 in adult men. Steroids 2012;77(1-2):52-8.

7

305. Perez-Castro C, Renner U, Haedo MR, Stalla GK, Arzt E. Cellular and molecular specificity of pituitary

gland physiology. Physiol Rev 2012;92(1):1-38.

304. Leistner DM, Klotsche J, Pieper L, Stalla GK, Lehnert H, Silber S, März W, Wittchen H-, Zeiher AM.

Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary

prevention. Clin Chem 2012;58(1):200-8.

303. Schneider HJ, Klotsche J, Wittchen H-, Stalla GK, Schopohl J, Kann PH, Kreitschmann-Andermahr I,

Wallaschofski H. Effects of growth hormone replacement within the KIMS survey on estimated

cardiovascular risk and predictors of risk reduction in patients with growth hormone deficiency. Clin

Endocrinol (Oxf) 2011;75(6):825-30.

302. Hartleb S, Plöckinger U, Stalla GK, Tuschy U, Weber MM, Pfützner A, Kann PH. Additive effect of

GHRd3 and COLIA1 polymorphisms on the GH-substitution dose in GH-deficient adults.

Pharmacogenomics 2011;12(12):1653-61.

301. AnonymousPrettyCLP: A light java implementation for teaching CLP. CEUR workshop proceedings;

2011. 281 p.

300. Malysheva O, Wagner U, Wahle M, Pierer M, Wagner U, Stalla GK, Baerwald CGO. Hypothalamic-

pituitary-adrenal axis stress test in patients with early RA: Role of corticotropinreleasing hormone

promoter polymorphisms. Ann Rheum Dis 2011;70(11):2058-9.

299. Baur DM, Klotsche J, Hamnvik O-R, Sievers C, Pieper L, Wittchen H-, Stalla GK, Schmid RM, Kales

SN, Mantzoros CS. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated

with risk for and mortality from cancer in a german primary care cohort. Metabolism: Clinical and

Experimental 2011;60(10):1363-71.

298. Tichomirowa MA, Barlier A, Daly AF, Jaffrain-Rea M-, Ronchi C, Yaneva M, Urban JD, Petrossians P,

Elenkova A, Tabarin A, Desailloud R, Maiter D, Schürmeyer T, Cozzi R, Theodoropoulou M, Sievers C,

Bernabeu I, Naves LA, Chabre O, Montañana CF, Hana V, Halaby G, Delemer B, Labarta Aizpún JI,

Sonnet E, Ferrandez Longás A, Hagelstein M-, Caron P, Stalla GK, Bours V, Zacharieva S, Spada A,

Brue T, Beckers A. High prevalence of AIP gene mutations following focused screening in young

patients with sporadic pituitary macroadenomas. Eur J Endocrinol 2011;165(4):509-15.

297. Castillo V, Theodoropoulou M, Stalla J, Gallelli MF, Cabrera-Blatter MF, Haedo MR, Labeur M,

Schmid HA, Stalla GK, Arzt E. Effect of SOM230 (pasireotide) on corticotropic cells: Action in dogs

with cushing's disease. Neuroendocrinology 2011;94(2):124-36.

296. Schneider HJ, Schneider M, Kreitschmann-Andermahr I, Tuschy U, Wallaschofski H, Fleck S, Faust M,

Renner CIE, Kopczak A, Saller B, Buchfelder M, Jordan M, Stalla GK. Structured assessment of

hypopituitarism after traumatic brain injury and aneurysmal subarachnoid hemorrhage in 1242 patients:

The german interdisciplinary database. J Neurotrauma 2011;28(9):1693-8.

295. Reiter MH, Vila G, Knosp E, Baumgartner-Parzer SM, Wagner L, Stalla GK, Luger A. Opposite effects

of serum- and glucocorticoid-regulated kinase-1 and glucocorticoids on POMC transcription and ACTH

release. American Journal of Physiology - Endocrinology and Metabolism 2011;301(2):E336-41.

294. Künzel HE, Murck H, Stalla GK, Steiger A. Changes in the sleep electroencephalogram (EEG) during

male to female transgender therapy. Psychoneuroendocrinology 2011;36(7):1005-9.

293. Schneider HJ, Kosilek RP, Günther M, Roemmler J, Stalla GK, Sievers C, Reincke M, Schopohl J,

Würtz RP. A novel approach to the detection of acromegaly: Accuracy of diagnosis by automatic face

classification. J Clin Endocrinol Metab 2011;96(7):2074-80.

292. Occhi G, Losa M, Albiger N, Trivellin G, Regazzo D, Scanarini M, Monteserin-Garcia JL, Fröhlich B,

Ferasin S, Terreni MR, Fassina A, Vitiello L, Stalla G, Mantero F, Scaroni C. The glucose-dependent

insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative

somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells. J Neuroendocrinol

2011;23(7):641-9.

291. Friedrich N, Schneider H, Dörr M, Nauck M, Völzke H, Klotsche J, Sievers C, Pittrow D, Böhler S,

Lehnert H, Pieper L, Wittchen H-, Wallaschofski H, Stalla GK. All-cause mortality and serum insulin-

like growth factor I in primary care patients. Growth Horm IGF Res 2011;21(2):102-6.

290. Schneider HJ, Friedrich N, Klotsche J, Schipf S, Nauck M, Völzke H, Sievers C, Pieper L, März W,

Wittchen H-, Stalla GK, Wallaschofski H. Prediction of incident diabetes mellitus by baseline IGF1

levels. Eur J Endocrinol 2011;164(2):223-9.

289. Kreitschmann-Andermahr I, Hartmann Y, Poll E, Schneider HJ, Buchfelder M, Stalla GK. The german

database on hypopituitarism after traumatic brain injury and aneurysmal subarachnoid hemorrhage -

description, objectives and design. Exp Clin Endocrinol Diabetes 2011;119(1):15-20.

288. Kopczak A, Von Rosen F, Krewer C, Schneider HJ, Stalla GK, Schneider M. Differences in the insulin

tolerance test in patients with brain damage depending on posture. Eur J Endocrinol 2011;164(1):31-6.

287. Schneider HJ, Klotsche J, Silber S, Stalla GK, Wittchen H-. Measuring abdominal obesity: Effects of

height on distribution of cardiometabolic risk factors risk using waist circumference and waist-to-height

ratio. Diabetes Care 2011;34(1).

8

286. Paslakis G, Lecei O, Stalla GK, Landgraf R, Uhr M, Hamann B, Luppa P, Gilles M, Heuser I, Deuschle

M. The effect of treatment with ketoconazole on central CRH systems of depressed patients. Human

Psychopharmacology 2011;26(1):35-40.

285. Ebinger M, Sievers C, Klotsche J, Schneider HJ, Leonards CO, Pieper L, Wittchen H-, Stalla GK, Endres

M. Triglycerides and stroke risk prediction: Lessons from a prospective cohort study in german primary

care patients. Front Neurol 2010;NOV.

284. Daly AF, Tichomirowa MA, Petrossians P, Heliövaara E, Jaffrain-Rea M-, Barlier A, Naves LA, Ebeling

T, Karhu A, Raappana A, Cazabat L, De Menis E, Montañana CF, Raverot G, Weil RJ, Sane T, Maiter

D, Neggers S, Yaneva M, Tabarin A, Verrua E, Eloranta E, Murat A, Vierimaa O, Salmela PI, Emy P,

Toledo RA, Sabaté MI, Villa C, Popelier M, Salvatori R, Jennings J, Longás ÁF, Aizpún JIL, Georgitsi

M, Paschke R, Ronchi C, Valimaki M, Saloranta C, De Herder W, Cozzi R, Guitelman M, Magri F,

Lagonigro MS, Halaby G, Corman V, Hagelstein M-, Vanbellinghen J-, Barra GB, Gimenez-Roqueplo

A-, Cameron FJ, Borson-Chazot F, Holdaway I, Toledo SPA, Stalla GK, Spada A, Zacharieva S,

Bertherat J, Brue T, Bours V, Chanson P, Aaltonen LA, Beckers A. Clinical characteristics and

therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: An international

collaborative study. J Clin Endocrinol Metab 2010;95(11):E373-83.

283. Sievers C, Klotsche J, Pieper L, Schneider HJ, März W, Wittchen HU, Stalla GK, Mantzoros C. Low

testosterone levels predict all-cause mortality and cardiovascular events in women: A prospective cohort

study in german primary care patients. European Journal of Endocrinology 2010;163(4):699-708.

282. Dimopoulou C, Sievers C, Wittchen HU, Pieper L, Klotsche J, Roemmler J, Schopohl J, Schneider HJ,

Stalla GK. Adverse anthropometric risk profile in biochemically controlled acromegalic patients:

Comparison with an age- and gender-matched primary care population. Pituitary 2010;13(3):207-14.

281. Labeur M, Páez-Pereda M, Haedo M, Arzt E, Stalla GK. Pituitary tumors: Cell type-specific roles for

BMP-4. Mol Cell Endocrinol 2010;326(1-2):85-8.

280. Theodoropoulou M, Stalla GK, Spengler D. ZAC1 target genes and pituitary tumorigenesis. Mol Cell

Endocrinol 2010;326(1-2):60-5.

279. Fuertes M, Gerez J, Haedo M, Giacomini D, Páez-Pereda M, Labeur M, Stalla GK, Arzt E. Cytokines

and genes in pituitary tumorigenesis: RSUME role in cell biology. Front Horm Res 2010;38:1-6.

278. Theodoropoulou M, Labeur M, Paez Pereda M, Haedo M, Perone MJ, Renner U, Arzt E, Stalla GK.

Novel medical therapies for pituitary tumors. Front Horm Res 2010;38:158-64.

277. Berg C, Petersenn S, Lahner H, Herrmann BL, Buchfelder M, Droste M, Stalla GK, Strasburger CJ,

Roggenbuck U, Lehmann N, Moebus S, Jöckel K-, Möhlenkamp S, Erbel R, Saller B, Mann K.

Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: Comparison with

matched data from the general population and the effect of disease control. J Clin Endocrinol Metab

2010;95(8):3648-56.

276. Sievers C, Brübach K, Saller B, Schneider HJ, Buchfelder M, Droste M, Mann K, Strasburger CJ, Stalla

GK. Change of symptoms and perceived health in acromegalic patients on pegvisomant therapy: A

retrospective cohort study within the german pegvisomant observational study (GPOS). Clin Endocrinol

(Oxf) 2010;73(1):89-94.

275. Petersenn S, Quabbe H-, Schöfl C, Stalla GK, Von Werder K, Buchfelder M. The rational use of pituitary

stimulation tests. Deutsches Ärzteblatt 2010;107(25):437-43.

274. Schneider HJ, Friedrich N, Klotsche J, Pieper L, Nauck M, John U, Dörr M, Felix S, Lehnert H, Pittrow

D, Silber S, Völzke H, Stalla GK, Wallaschofski H, Wittchen H-. The predictive value of different

measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab

2010;95(4):1777-85.

273. Kowarik M, Onofri C, Colaco T, Stalla GK, Renner U. Platelet-derived growth factor (PDGF) and PDGF

receptor expression and function in folliculostellate pituitary cells. Exp Clin Endocrinol Diabetes

2010;118(2):113-20.

272. Schaaf C, Shan B, Onofri C, Stalla GK, Arzt E, Schilling T, Perone MJ, Renner U. Curcumin inhibits the

growth, induces apoptosis and modulates the function of pituitary folliculostellate cells.


271. Cerovac V, Monteserin-Garcia J, Rubinfeld H, Buchfelder M, Losa M, Florio T, Paez-Pereda M, Stalla

GK, Theodoropoulou M. The somatostatin analogue octreotide confers sensitivity to rapamycin treatment

on pituitary tumor cells. Cancer Res 2010;70(2):666-74.

270. Meyer S, Schaefer S, Stolk L, Arp P, Uitterlinden AG, Plöckinger U, Stalla GK, Tuschy U, Weber MM,

Weise A, Pfützner A, Kann PH. Association of the exon 3 deleted/full-length GHR polymorphism with

recombinant growth hormone dose in growth hormone-deficient adults. Pharmacogenomics

2009;10(10):1599-608.

269. Schaaf C, Shan B, Buchfelder M, Losa M, Kreutzer J, Rachinger W, Stalla GK, Schilling T, Arzt E,

Perone MJ, Renner U. Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and

human pituitary tumour cells in vitro and in vivo. Endocr Relat Cancer 2009;16(4):1339-50.

9

268. Touraine P, D'Souza GA, Kourides I, Abs R, Barclay P, Xie R, Pico A, Torres-Vela E, Ekman B,

Andersen M, Beck-Peccoz P, Beckers A, Bex MA, Bornstein SR, Cannavo S, Cap J, Chanson P, Colao

AM, Faust M, Halperin I, Karbownik-Lewinska M, De Marinis L, Drake WM, Erfurth EM, Ghigo E,

Hana V, Kann PH, Laurberg P, Miell JP, Milewicz A, Payer J, Pereira AM, T'Sjoen G, Sowinski J, Stalla

GK, Trainer PJ, Wass J, Brue T, Casanueva FF, Czernichow P, Delemer B, De Schepper J, Feldt-

Rasmussen U, Gregory JW, Jørgensen JOL, Johannsson G, Kristensen LO, Mattsson C, Pura M, Vanuga

P. Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH. Eur J Endocrinol

2009;161(4):533-40.

267. Buchfelder M, Schlaffer S, Droste M, Mann K, Saller B, Brübach K, Stalla GK, Strasburger CJ. The

german ACROSTUDY: Past and present. Eur J Endocrinol 2009;161(SUPPL. 1):S3-S10.

266. Theodoropoulou M, Tichomirowa MA, Sievers C, Yassouridis A, Arzberger T, Hougrand O, Deprez M,

Daly AF, Petrossians P, Pagotto U, Beckers A, Stalla GK. Tumor ZAC1 expression is associated with the

response to somatostatin analog therapy in patients with acromegaly. Int J Cancer 2009;125(9):2122-6.

265. Sievers C, Dimopoulou C, Pfister H, Lieb R, Steffin B, Roemmler J, Schopohl J, Mueller M, Schneider

HJ, Ising M, Wittchen HU, Stalla GK. Prevalence of mental disorders in acromegaly: A cross-sectional

study in 81 acromegalic patients. Clin Endocrinol (Oxf) 2009;71(5):691-701.

264. Schaaf L, Stalla GK. Endocrine changes with advancing age - selected examples and practical

consequences. MMW-Fortschritte Der Medizin 2009;151(42):43-5.

263. Haedo MR, Gerez J, Fuertes M, Giacomini D, Páez-Pereda M, Labeur M, Renner U, Stalla GK, Arzt E.

Regulation of pituitary function by cytokines. Horm Res 2009;72(5):266-74.

262. Correa-de-Santana E, Fröhlich B, Labeur M, Páez-Pereda M, Theodoropoulou M, Monteserin JL, Renner

U, Stalla GK. NOD2 receptors in adenopituitary folliculostellate cells: Expression and function. J

Endocrinol 2009;203(1):111-22.

261. Buchfelder M, Weigel D, Droste M, Mann K, Saller B, Brübach K, Stalla GK, Bidlingmaier M,

Strasburger CJ. Pituitary tumor size in acromegaly during pegvisomant treatment: Experience from MR

re-evaluations of the german pegvisomant observational study. Eur J Endocrinol 2009;161(1):27-35.

260. Ebinger M, Sievers C, Ivan D, Schneider HJ, Stalla GK. Is there a neuroendocrinological rationale for

testosterone as a therapeutic option in depression? Journal of Psychopharmacology 2009;23(7):841-53.

259. Gorshtein A, Rubinfeld H, Kendler E, Theodoropoulou M, Cerovac V, Stalla GK, Cohen ZR, Hadani M,

Shimon I. Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-

proliferative effects in GH-secreting pituitary tumor cells in vitro. Endocr Relat Cancer 2009;16(3):1017-

27.

258. Giacomini D, Páez-Pereda M, Stalla J, Stalla GK, Arzt E. Molecular interaction of BMP-4, TGF-β, and

estrogens in lactotrophs: Impact on the PRL promoter. Mol Endocrinol 2009;23(7):1102-14.

257. Meyer S, Schaefer S, Ivan D, Stolk L, Arp P, Uitterlinden AG, Nawroth PP, Plöckinger U, Stalla GK,

Tuschy U, Weber MM, Weise A, Pfützner A, Kann PH. Growth hormone dose in growth hormone-

deficient adults is not associated with IGF-1 gene polymorphisms. Pharmacogenomics 2009;10(2):293-

302.

256. Labeur M, Paez-Pereda M, Arzt E, Stalla GK. Potential of retinoic acid derivatives for the treatment of

corticotroph pituitary adenomas. Rev Endocr Metabol Disorders 2009;10(2):103-9.

255. Sievers C, Ising M, Pfister H, Dimopoulou C, Schneider HJ, Roemmler J, Schopohl J, Stalla GK.

Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits:

Comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age-

and gender-matched controls. Eur J Endocrinol 2009;160(3):367-73.

254. Giacomini D, Haedo M, Gerez J, Druker J, Páez-Pereda M, Labeur M, Stalla GK, Arzt E. Differential

gene expression in models of pituitary prolactin-producing tumoral cells. Horm Res 2009;71(SUPPL.

2):88-94.

253. Arzt E, Chesnokova V, Stalla GK, Melmed S. Pituitary adenoma growth: A model for cellular

senescence and cytokine action. Cell Cycle 2009;8(5):677-8.

252. Corrêa-De-Santana E, Paez-Pereda M, Theodoropoulou M, Renner U, Stalla J, Stalla GK, Savino W.

Modulation of growth hormone and prolactin secretion in trypanosoma cruzi-infected

mammosomatotrophic cells. Neuroimmunomodulation 2009;16(3):208-12.

251. Schneider HJ, Sievers C, Klotsche J, Böhler S, Pittrow D, Lehnert H, Wittchen H-, Stalla GK. Prevalence

of low male testosterone levels in primary care in germany: Cross-sectional results from the DETECT

study. Clin Endocrinol (Oxf) 2009;70(3):446-54.

250. Renner U, De Santana EC, Gerez J, Fröhlich B, Haedo M, Pereda MP, Onofri C, Stalla GK, Arzt E.

Intrapituitary expression and regulation of the gp130 cytokine interleukin-6 and its implication in

pituitary physiology and pathophysiology. Ann N Y Acad Sc 2009;1153:89-97.

249. Sievers C, Sämann PG, Dose T, Dimopoulou C, Spieler D, Roemmler J, Schopohl J, Mueller M,

Schneider HJ, Czisch M, Pfister H, Stalla GK. Macroscopic brain architecture changes and white matter

pathology in acromegaly: A clinicoradiological study. Pituitary 2009;12(3):177-85.

10

248. Giacomini D, Acuña M, Nagashima AC, Castro CP, Páez-Pereda M, Renner U, Stalla GK, Arzt E.

Inflammatory mediator action on the anterior pituitary gland. NeuroImmune Biology 2008;7(C):241-58.

247. Lu A, Steiner MA, Whittle N, Vogl AM, Walser SM, Ableitner M, Refojo D, Ekker M, Rubenstein JL,

Stalla GK, Singewald N, Holsboer F, Wotjak CT, Wurst W, Deussing JM. Conditional CRH

overexpressing mice: An animal model for stress-elicited pathologies and treatments that target the

central CRH system. Mol Psychiatry 2008;13(11):989.

246. Labeur M, Refojo D, Wölfel B, Stalla J, Vargas V, Theodoropoulou M, Buchfelder M, Paez-Pereda M,

Arzt E, Stalla GK. Interferon-γ inhibits cellular proliferation and ACTH production in corticotroph tumor

cells through a novel janus kinases-signal transducer and activator of transcription 1/nuclear factor-kappa

B inhibitory signaling pathway. J Endocrinol 2008;199(2):177-89.

245. Lu A, Steiner MA, Whittle N, Vogl AM, Walser SM, Ableitner M, Refojo D, Ekker M, Rubenstein JL,

Stalla GK, Singewald N, Holsboer F, Wotjak CT, Wurst W, Deussing JM. Conditional mouse mutants

highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior. Mol

Psychiatry 2008;13(11):1028-42.

244. Tichomirowa MA, Theodoropoulou M, Daly AF, Yassouridis A, Hansen S, Lu J, Lange M, Goldbrunner

RH, Stalla GK, Renner U. Toll-like receptor-4 is expressed in meningiomas and mediates the

antiproliferative action of paclitaxel. International Journal of Cancer 2008;123(8):1956-63.

243. Kronsbein HC, Jastorff AM, Maccarrone G, Stalla G, Wurst W, Holsboer F, Turck CW, Deussing JM.

CRHR1-dependent effects on protein expression and posttranslational modification in AtT-20 cells. Mol

Cell Endocrinol 2008;292(1-2):1-10.

242. Schneider HJ, Sievers C, Saller B, Wittchen HU, Stalla GK. High prevalence of biochemical acromegaly

in primary care patients with elevated IGF-1 levels. Clin Endocrinol (Oxf) 2008;69(3):432-5.

241. Meyer S, Haist M, Schaefer S, Ivan D, Ittner JR, Nawroth PP, Plöckinger U, Stalla GK, Tuschy U,

Weber MM, Weise A, Pfützner A, Habbe N, Kann PH. Association of COLIA1 Sp1 polymorphism with

the effect of subcutaneously injected recombinant hGH in GH-deficient adults. Pharmacogenomics

2008;9(8):1017-26.

240. Biller BMK, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A,

Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S,

Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JAH, Boscaro M. Treatment of

adrenocorticotropin-dependent cushing's syndrome: A consensus statement. J Clin Endocrinol Metab

2008;93(7):2454-62.

239. Sievers C, Schneider HJ, Stalla GK. Insulin-like growth factor-1 in plasma and brain: Regulation in

health and disease. Frontiers in Bioscience 2008;13(1):85-99.

238. Webb SM, Badia X, Baarahona MJ, Colao A, Strasburger CJ, Tabarin A, van Aken MO, Pivonello R,

Stalla G, Lamberts SWJ, Glusman JE. Evaluation of health-related quality of life in patients with

cushing's syndrome with a new questionnaire. European Journal of Endocrinology 2008;158(5):623-30.

237. Göncz E, Strowski MZ, Grötzinger C, Nowak KW, Kaczmarek P, Sassek M, Mergler S, El-Zayat BF,

Theodoropoulou M, Stalla GK, Wiedenmann B, Plöckinger U. Orexin-a inhibits glucagon secretion and

gene expression through a Foxo1-dependent pathway. Endocrinology 2008;149(4):1618-26.

236. Onofri C, Losa M, Uhl E, Stalla GK, Renner U. Immunohistochemical analysis of VEGF-C/VEGFR-3

system and lymphatic vessel extent in normal and adenomatous human pituitary tissues. Experimental

and Clinical Endocrinology and Diabetes 2008;116(3):152-7.

235. Schneider HJ, Klotsche J, Saller B, Böhler S, Sievers C, Pittrow D, Ruf G, März W, Erwa W, Zeiher

AM, Silber S, Lehnert H, Wittchen H-, Stalla GK. Associations of age-dependent IGF-I SDS with

cardiovascular diseases and risk conditions: Cross-sectional study in 6773 primary care patients.

European Journal of Endocrinology 2008;158(2):153-61.

234. Schneider M, Schneider HJ, Yassouridis A, Saller B, Von Rosen F, Stalla GK. Predictors of anterior

pituitary insufficiency after traumatic brain injury. Clin Endocrinol (Oxf) 2008;68(2):206-12.

233. Fulda S, Stalla GK, Wetter TC. Prevalence of the restless legs syndrome in transsexual patients: The

hormonal hypothesis revisited [4]. J Neurol 2007;254(12):1748-9.

232. Backmund M, Schneider HJ, Stalla GK. Case reports about weight loss with a media-supported weight-

loss program. Suchtmedizin in Forschung Und Praxis 2007;9(4):219-22.

231. Strasburger CJ, Buchfelder M, Droste M, Mann K, Stalla GK, Saller B. Experience from the german

pegvisomant observational study. Horm Res 2007;68 Suppl 5:70-3.

230. de Kloet CS, Vermetten E, Geuze E, Lentjes EGWM, Heijnen CJ, Stalla GK, Westenberg HGM.

Elevated plasma corticotrophin-releasing hormone levels in veterans with posttraumatic stress disorder.

Progress in Brain Research 2007;167:287-91.

229. Carbia-Nagashima A, Gerez J, Perez-Castro C, Paez-Pereda M, Silberstein S, Stalla GK, Holsboer F,

Arzt E. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1α

during hypoxia. Cell 2007;131(2):309-23.

11

228. Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A. Hypothalamopituitary

dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: A systematic

review. J Am Med Assoc 2007;298(12):1429-38.

227. Schaaf L, Pickel J, Zinner K, Hering U, Höfler M, Goretzki PE, Spelsberg F, Raue F, Von Zur Mühlen

A, Gerl H, Hensen J, Bartsch DK, Rothmund M, Schneyer U, Dralle H, Engelbach M, Karges W, Stalla

GK, Höppner W. Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN

1) on the basis of clinical and sequencing data of german patients with MEN 1. Experimental and


226. Gerez J, Bonfiglio J, Sosa S, Giacomini D, Acuña M, Carbia Nagashima A, Perone MJ, Silberstein S,

Renner U, Stalla GK, Arzt E. Molecular transduction mechanisms of cytokine-hormone interactions:

Role of gp130 cytokines. Exp Physiol 2007;92(5):801-6.

225. Meyer S, Ipek M, Keth A, Minnemann T, von Mach MA, Weise A, Ittner JR, Nawroth PP, Plöckinger U,

Stalla GK, Tuschy U, Weber MM, Kann PH. Short stature and decreased insulin-like growth factor I

(IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH

insensitivity due to a R179C mutation of the growth hormone receptor. Growth Hormone and IGF

Research 2007;17(4):307-14.

224. Giacomini D, Acuña M, Gerez J, Nagashima AC, Silberstein S, Páez-Pereda M, Labeur M,

Theodoropoulou M, Renner U, Stalla GK, Arzt E. Pituitary action of cytokines: Focus on BMP-4 and

gp130 family. Neuroendocrinology 2007;85(2):94-100.

223. Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla G-, Ghigo E. Hypopituitarism. Lancet

2007;369(9571):1461-70.

222. Schneider HJ, Sämann PG, Schneider M, Croce CG, Corneli G, Sievers C, Ghigo E, Stalla GK, Aimaretti

G. Pituitary imaging abnormalities in patients with and without hypopituitarism after traumatic brain

injury. J Endocrinol Invest 2007;30(4):RC9-RC12.

221. Cota D, Steiner M-, Marsicano G, Cervino C, Herman JP, Grübler Y, Stalla J, Pasquali R, Lutz B, Stalla

GK, Pagotto U. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-

pituitary-adrenal axis function. Endocrinology 2007;148(4):1574-81.

220. Böhler S, Scharnagl H, Freisinger F, Stojakovic T, Glaesmer H, Klotsche J, Pieper L, Pittrow D, Kirch

W, Schneider H, Stalla GK, Lehnert H, Zeiher AM, Silber S, Koch U, Ruf G, März W, Wittchen H-.

Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in germany.

Atherosclerosis 2007;190(2):397-407.

219. Schneider HJ, Glaesmer H, Klotsche J, Böhler S, Lehnert H, Zeiher AM, März W, Pittrow D, Stalla GK,

Wittchen H-. Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J Clin

Endocrinol Metab 2007;92(2):589-94.

218. Dimopoulou C, Stalla GK. Lithium therapy and diabetes insipidus renalis. Internist Prax 2006;46(4):805-

6.

217. Dimopoulou C, Stalla GK. Lithium therapy and diabetes insipidus renalis. Tagliche Praxis

2006;47(4):748-9.

216. Druker J, Liberman AC, Acuña M, Giacomini D, Refojo D, Silberstein S, Pereda MP, Stalla GK,

Holsboer F, Arzt E. Molecular understanding of cytokine-steroid hormone dialogue: Implications for

human diseases. Annals of the New York Academy of Sciences 2006;1088:297-306.

215. Stalla G. Pituitary insufficiency. underestimated complication after head and brain injuries? interview by

johannes weiss. Deutsche Medizinische Wochenschrift (1946) 2006;Suppl 1:46.

214. Schneider HJ, Herrmann BL, Schneider M, Sievers C, Schaaf L, Stalla GK. Discrepant results in the

diagnosis of GH deficiency with the insulin-tolerance test and the GHRH plus arginine test in patients

with traumatic brain injury. European Journal of Endocrinology 2006;155(4):553-7.

213. Schneider HJ, Rovere S, Corneli G, Croce CG, Gasco V, Rudà R, Grotolli S, Stalla GK, Soffietti R,

Ghigo E, Aimaretti G. Endocrine dysfunction in patients operated on for non-pituitary intracranial

tumors. European Journal of Endocrinology 2006;155(4):559-66.

212. Onofri C, Theodoropoulou M, Losa M, Uhl E, Lange M, Arzt E, Stalla GK, Renner U. Localization of

vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: Detection of

a non-endothelial function of VEGF in pituitary tumours. J Endocrinol 2006;191(1):249-61.

211. Castillo V, Giacomini D, Páez-Pereda M, Stalla J, Labeur M, Theodoropoulou M, Holsboer F, Grossman

AB, Stalla GK, Arzt E. Retinoic acid as a novel medical therapy for cushing's disease in dogs.

Endocrinology 2006;147(9):4438-44.

210. Pittrow D, Stalla GK, Zeiher AM, Silber S, März W, Pieper L, Klotsche J, Glaesmer H, Ruf G, Schneider

HJ, Lehnert H, Böhler S, Koch U, Wittchen H-. Prevalence, drug treatment and metabolic control of

diabetes mellitus in primary care. Med Klin 2006;101(8):635-44.

209. Labeur M, Theodoropoulou M, Sievers C, Paez-Pereda M, Castillo V, Arzt E, Stalla GK. New aspects in

the diagnosis and treatment of cushing disease. Frontiers of Hormone Research 2006;35:169-78.

12

208. Giacomini D, Páez-Pereda M, Theodoropoulou M, Gerez J, Nagashima AC, Chervin A, Berner S, Labeur

M, Refojo D, Renner U, Stalla GK, Arzt E. Bone morphogenetic protein-4 control of pituitary

pathophysiology. Frontiers of Hormone Research 2006;35:22-31.

207. Schneider HJ, Saller B, Klotsche J, März W, Erwa W, Wittchen H-, Stalla GK. Opposite associations of

age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal

weight and obese subjects. European Journal of Endocrinology 2006;154(5):699-706.

206. Corrêa-De-Santana E, Paez-Pereda M, Theodoropoulou M, Kenji Nihei O, Gruebler Y, Bozza M, Arzt E,

Villa-Verde DMS, Renner U, Stalla J, Stalla GK, Savino W. Hypothalamus-pituitary-adrenal axis during

trypanosoma cruzi acute infection in mice. J Neuroimmunol 2006;173(1-2):12-22.

205. Schneider HJ, Klotsche J, Stalla GK, Wittchen H-. Obesity and risk of myocardial infarction: The

INTERHEART study. Lancet 2006;367(9516):1052.

204. Schneider HJ, Stalla GK, Buchfelder M. Expert meeting: Hypopituitarism after traumatic brain injury

and subarachnoid haemorrhage. Acta Neurochir 2006;148(4):449-56.

203. Schneider HJ, Pickel J, Stalla GK. Typical female 2nd-4th finger length (2D:4D) ratios in male-to-female

transsexuals - possible implications for prenatal androgen exposure. Psychoneuroendocrinology

2006;31(2):265-9.

202. Theodoropoulou M, Zhang J, Laupheimer S, Paez-Pereda M, Erneux C, Florio T, Pagotto U, Stalla GK.

Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by

altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression. Cancer Res

2006;66(3):1576-82.

201. Schneider HJ, Schneider M, Saller B, Petersenn S, Uhr M, Husemann B, von Rosen F, Stalla GK.

Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury. European

Journal of Endocrinology 2006;154(2):259-65.

200. Giacomini D, Páez-Pereda M, Theodoropoulou M, Labeur M, Refojo D, Gerez J, Chervin A, Berner S,

Losa M, Buchfelder M, Renner U, Stalla GK, Arzt E. Bone morphogenetic protein-4 inhibits corticotroph

tumor cells: Involvement in the retinoic acid inhibitory action. Endocrinology 2006;147(1):247-56.

199. Vila G, Theodoropoulou M, Stalla J, Tonn JC, Losa M, Renner U, Stalla GK, Paez-Pereda M. Expression

and function of sonic hedgehog pathway components in pituitary adenomas: Evidence for a direct role in

hormone secretion and cell proliferation. J Clin Endocrinol Metab 2005;90(12):6687-94.

198. Schneider H, Stalla GK. The somatotropic axis in psychologic functioning. effects on sleep and

psychopathology. The Somatotrophic Axis in Brain Function 2005:231-6.

197. Pieper L, Wittchen H-, Glaesmer H, Klotsche J, März W, Stalla G, Lehnert H, Zeiher AM, Silber S,

Koch U, Böhler S, Pittrow D, Ruf G. Cardiovascular high-risk constellations in primary care. DETECT

study 2003. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 2005;48(12):1374-82.

196. Páez-Pereda M, Stalla GK. Chapter 1.4 hormones of the pituitary. Techniques in the Behavioral and

Neural Sciences 2005;15(PART 1):67-77.

195. Tichomirowa MA, Keck ME, Schneider HJ, Paez-Pereda M, Renner U, Holsboer F, Stalla GK.

Endocrine disturbances in depression. J Endocrinol Invest 2005;28(1):89-99.

194. Sievers C, Schneider HJ, Stalla GK. The genetics of hypogonadotropic hypogonadism in the male.

MMW-Fortschritte Der Medizin 2005;147(45):32-6.

193. Paez-Pereda M, Kuchenbauer F, Arzt E, Stalla GK. Regulation of pituitary hormones and cell

proliferation by components of the extracellular matrix. Brazilian Journal of Medical and Biological

Research 2005;38(10):1487-94.

192. Schneider M, Schneider HJ, Stalla GK. Anterior pituitary hormone abnormalities following traumatic

brain injury. J Neurotrauma 2005;22(9):937-46.

191. Paez-Pereda M, Giacomini D, Echenique C, Stalla GK, Holsboer F, Arzt E. Signaling processes in

tumoral neuroendocrine pituitary cells as potential targets for therapeutic drugs. Current Drug Targets:

Immune, Endocrine and Metabolic Disorders 2005;5(3):259-67.

190. Ghigo E, Masel B, Aimaretti G, Léon-Carrión J, Casanueva FF, Dominguez-Morales MR, Elovic E,

Perrone K, Stalla G, Thompson C, Urban R. Consensus guidelines on screening for hypopituitarism

following traumatic brain injury. Brain Injury 2005;19(9):711-24.

189. Gutt B, Wowra B, Alexandrov R, Uhl E, Schaaf L, Stalla GK, Schopohl J. Gamma-knife surgery is

effective in normalising plasma insulin-like growth factor I in patients with acromegaly. Experimental

and Clinical Endocrinology and Diabetes 2005;113(4):219-24.

188. Wittchen H-, Glaesmer H, März W, Stalla G, Lehnert H, Zeiher AM, Silber S, Koch U, Böhler S, Pittrow

D, Ruf G. Cardiovascular risk factors in primary care: Methods and baseline prevalence rates - the

DETECT program. Curr Med Res Opin 2005;21(4):619-29.

187. Tichomirowa M, Theodoropoulou M, Lohrer P, Schaaf L, Losa M, Uhl E, Lange M, Arzt E, Stalla GK,

Renner U. Bacterial endotoxin (lipopolysaccharide) stimulates interleukin-6 production and inhibits

growth of pituitary tumour cells expressing the toll-like receptor 4. J Neuroendocrinol 2005;17(3):152-

60.

13

186. Newton CJ, Bilko D, Tichomirowa M, Renner U, Stalla GK. The role of poly (adenosine 5 ′-diphosphate-

ribose) polymerase in the response of pituitary tumor cells to reactive oxygen species. Endocrinology

2005;146(3):1119-27.

185. Vila G, Papazoglou M, Stalla J, Theodoropoulou M, Stalla GK, Holsboer F, Paez-Pereda M. Sonic

hedgehog regulates CRH signal transduction in the adult pituitary. FASEB Journal 2005;19(2):281-3.

184. Schneider HJ, Oertel H, Murck H, Pollmächer T, Stalla GK, Steiger A. Night sleep EEG and daytime

sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six

months of growth hormone replacement. Psychoneuroendocrinology 2005;30(1):29-37.

183. Renner U, Paez-Pereda M, Arzt E, Stalla GK. Growth factors and cytokines: Function and molecular

regulation in pituitary adenomas. Frontiers of Hormone Research 2004;32:96-109.

182. Labeur M, Arzt E, Stalla GK, Péz-Pereda M. New perspectives in the treatment of cushing's syndrome.

Current Drug Targets: Immune, Endocrine and Metabolic Disorders 2004;4(4):335-42.

181. Theodoropoulou M, Arzberger T, Gruebler Y, Jaffrain-Rea ML, Schlegel J, Schaaf L, Petrangeli E, Losa

M, Stalla GK, Pagotto U. Expression of epidermal growth factor receptor in neoplastic pituitary cells:

Evidence for a role in corticotropinoma cells. J Endocrinol 2004;183(2):385-94.

180. Graciarena M, Carbia-Nagashima A, Onofri C, Perez-Castro C, Giacomini D, Renner U, Stalla GK, Arzt

E. Involvement of the gp130 cytokine transducer in MtT/S pituitary somatotroph tumour development in

an autocrine-paracrine model. European Journal of Endocrinology 2004;151(5):595-604.

179. Schneider HJ, Stalla GK. Pituitary incidentaloma. MMW-Fortschritte Der Medizin 2004;146(43):67-8.

178. Schneider HJ, Stalla GK, Schneider M, Von Rosen F, Uhl E. Pituitary insufficiency following head

injury - how common is it, and what is to be done? MMW-Fortschritte Der Medizin 2004;146(41):41-4.

177. Vlotides G, Zitzmann K, Stalla GK, Auernhammer CJ. Novel neurotrophin-1/B cell-stimulating factor-3

(NNT-1/BSF-3) / cardiotrophin-like cytokine (CLC) - A novel gp130 cytokine with pleiotropic functions.

Cytokine and Growth Factor Reviews 2004;15(5):325-36.

176. Nieschlag E, Behre HM, Bouchard P, Corrales JJ, Jones TH, Stalla GK, Webb SM, Wu FCW.

Testosterone replacement therapy: Current trends and future directions. Hum Reprod Update

2004;10(5):409-19.

175. Oertel H, Schneider HJ, Stalla GK, Holsboer F, Zihl J. The effect of growth hormone substitution on

cognitive performance in adult patients with hypopituitarism. Psychoneuroendocrinology

2004;29(7):839-50.

174. Theodoropoulou M, Cavallari I, Barzon L, D'Agostino DM, Ferro T, Arzberger T, Grübler Y, Schaaf L,

Losa M, Fallo F, Ciminale V, Stalla GK, Pagotto U. Differential expression of menin in sporadic

pituitary adenomas. Endocr Relat Cancer 2004;11(2):333-44.

173. Korbonits M, Slawik M, Cullen D, Ross RJ, Stalla G, Schneider H, Reincke M, Bouloux PM, Grossman

AB. A comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone

adhesive patch in hypogonadal males. J Clin Endocrinol Metab 2004;89(5):2039-43.

172. Kovalovsky D, Paez Pereda M, Labeur M, Renner U, Holsboer F, Stalla GK, Arzt E. Nur77 induction

and activation are necessary for interleukin-1 stimulation of proopiomelanocortin in AtT-20

corticotrophs. FEBS Lett 2004;563(1-3):229-33.

171. Böhler S, Glaesmer H, Pittrow D, Lehnert H, Stalla GK, Zeiher AM, März W, Silber S, Wehling M, Ruf

G, Reinecke A, Wittchen H-. Diabetes and cardiovascular risk evaluation and management in primary

care: Progress and unresolved issues. rationale for a nationwide primary care project in germany.

Experimental and Clinical Endocrinology and Diabetes 2004;112(4):157-70.

170. Vlotides G, Zitzmann K, Hengge S, Engelhardt D, Stalla GK, Auernhammer CJ. Expression of novel

neurotrophin-1/B-cell stimulating factor-3 (NNT-1/BSF-3) in murine pituitary folliculostellate TtT/GF

cells. Endocrinology 2004;145(2):716-27.

169. Onofri C, Carbia Nagashima A, Schaaf L, Feirer M, Lohrer P, Stummer W, Berner S, Chervin A,

Goldberg V, Stalla GK, Renner U, Arzt E. Estradiol stimulates vascular endothelial growth factor and

interleukin-6 in human lactotroph and lactosomatotroph pituitary adenomas. Experimental and Clinical

Endocrinology and Diabetes 2004;112(1):18-23.

168. Schneider HJ, Pagotto U, Stalla GK. Central effects of the somatotropic system. European Journal of

Endocrinology 2003;149(5):377-92.

167. Thiele J-, Lohrer P, Schaaf L, Feirer M, Stummer W, Losa M, Lange M, Tichomirowa M, Arzt E, Stalla

GK, Renner U. Functional in vitro studies on the role and regulation of interleukin-6 in human

somatotroph pituitary adenomas. European Journal of Endocrinology 2003;149(5):455-61.

166. Kuchenbauer F, Theodoropoulou M, Hopfner U, Stalla J, Renner U, Tonn JC, Low MJ, Arzt E, Stalla

GK, Páez-Pereda M. Laminin inhibits lactotroph proliferation and is reduced in early prolactinoma

development. Mol Cell Endocrinol 2003;207(1-2):13-20.

165. Lob S, Pickel J, Bidlingmaier M, Schaaf L, Backmund H, Gerlinghoff M, Stalla GK. Serum leptin

monitoring in anorectic patients during refeeding therapy. Experimental and Clinical Endocrinology and

Diabetes 2003;111(5):278-82.

14

164. Cota D, Marsicano G, Tschöp M, Grübler Y, Flachskamm C, Schubert M, Auer D, Yassouridis A,

Thöne-Reineke C, Ortmann S, Tomassoni F, Cervino C, Nisoli E, Linthorst ACE, Pasquali R, Lutz B,

Stalla GK, Pagotto U. The endogenous cennabinoid system affects energy balance via central orexigenic

drive and peripheral lipogenesis. J Clin Invest 2003;112(3):423-31.

163. Refojo D, Liberman AC, Giacomini D, Nagashima AC, Graciarena M, Echenique C, Paez Pereda M,

Stalla G, Holsboer F, Arzt E. Integrating systemic information at the molecular level: Cross-talk between

steroid receptors and cytokine signaling on different target cells. Annals of the New York Academy of

Sciences 2003;992:196-204.

162. Marsicano G, Cota D, Stalla GK, Pasquali R, Pagotto U, Lutz B. Cannabinoids in energy balance and

prospectives in the therapy of obesity. Current Medicinal Chemistry - Central Nervous System Agents

2003;3(2):81-7.

161. Carbia Nagashima AC, Giacomini D, Perez Castro C, Paez Pereda M, Renner U, Stalla GK, Arzt E.

Transcriptional regulation of interleukin-6 in pituitary folliculo-stellate TtT/GF cells. Mol Cell

Endocrinol 2003;201(1-2):47-56.

160. Cota D, Marsicano G, Lutz B, Vicennati V, Stalla GK, Pasquali R, Pagotto U. Endogenous cannabinoid

system as a modulator of food intake. Int J Obes 2003;27(3):289-301.

159. Páez-Pereda M, Giacomini D, Refojo D, Nagashima AC, Hopfner U, Grübler Y, Chervin A, Goldberg V,

Goya R, Hentges ST, Low MJ, Holsboer F, Stalla GK, Arzt E. Involvement of bone morphogenetic

protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk.

Proc Natl Acad Sci U S A 2003;100(3):1034-9.

158. Perez Castro C, Giacomini D, Carbia Nagashima A, Onofri C, Graciarena M, Kobayashi K, Páez-Pereda

M, Renner U, Stalla GK, Arzt E. Reduced expression of the cytokine transducer gp130 inhibits hormone

secretion, cell growth, and tumor development of pituitary lactosomatotrophic GH3 cells. Endocrinology

2003;144(2):693-700.

157. Deuschle M, Lecei O, Stalla GK, Landgraf R, Hamann B, Lederbogen F, Uhr M, Luppa P, Maras A,

Colla M, Heuser I. Steroid synthesis inhibition with ketoconazole and its effect upon the regulation of the

hypothalamus-pituitary-adrenal system in healthy humans. Neuropsychopharmacology : Official

Publication of the American College of Neuropsychopharmacology 2003;28(2):379-83.

156. Korali Z, Wittchen HU, Pfister H, Höfler M, Oefelein W, Stalla GK. Are patients with pituitary

adenomas at an increased risk of mental disorders? Acta Psychiatr Scand 2003;107(1):60-8.

155. Castro CP, Pereda MP, Reul JMHM, Stalla GK, Holsboer F, Arzt E. In vivo changes of PRL levels

during the T-cell dependent immune response. NeuroImmune Biology 2002;2(C):219-26.

154. Páez-Pereda M, Arzt E, Stalla GK. Cushing's syndrome: Drug targets and therapeutic options. Expert

Opinion on Therapeutic Patents 2002;12(10):1537-46.

153. Renner U, Lohrer P, Schaaf L, Feirer M, Schmitt K, Onofri C, Arzt E, Stalla GK. Transforming growth

factor-β stimulates vascular endothelial growth factor production by folliculostellate pituitary cells.

Endocrinology 2002;143(10):3759-65.

152. Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F,

Arzt E. Activation and induction of Nur77/Nurr1 in corticotrophs by CRH/cAMP: Involvement of

calcium, protein kinase a, and MAPK pathways. Molecular Endocrinology 2002;16(7):1638-51.

151. Lange M, Pagotto U, Renner U, Arzberger T, Oeckler R, Stalla GK. The role of endothelins in the

regulation of pituitary function. Experimental and Clinical Endocrinology and Diabetes 2002;110(3):103-

12.

150. Winkelmann J, Pagotto U, Theodoropoulou M, Tatsch K, Saeger W, Müller A, Arzberger T, Schaaf L,

Schumann EM, Trenkwalder C, Stalla GK. Retention of dopamine 2 receptor mRNA and absence of the

protein in craniospinal and extracranial metastasis of a malignant prolactinoma: A case report. European

Journal of Endocrinology 2002;146(1):81-8.

149. Gloddek J, Lohrer P, Stalla J, Arzt E, Stalla GK, Renner U. The intrapituitary stimulatory effect of

lipopolysaccharide on ACTH secretion is mediated by paracrine-acting IL-6. Experimental and Clinical

Endocrinology and Diabetes 2001;109(8):410-5.

148. Páez-Pereda M, Kovalovsky D, Hopfner U, Theodoropoulou M, Pagotto U, Uhl E, Losa M, Stalla J,

Grübler Y, Missale C, Arzt E, Stalla GK. Retinoic acid prevents experimental cushing syndrome. J Clin

Invest 2001;108(8):1123-31.

147. Stalla GK, Schaaf L. Diseases of the pituitary. an alert family doctor can recognize the early symptoms.

MMW-Fortschritte Der Medizin 2001;143(44):27.

146. Goebel VC, Stalla GK. Presentation and diagnosis of pituitary diseases. MMW-Fortschritte Der Medizin

2001;143(44):28-34.

145. Dötsch J, Dörr HG, Stalla GK, Sippell WG. Effect of glucocorticoid excess on the cortisol/cortisone

ratio. Steroids 2001;66(11):817-20.

15

144. Müller MB, Preil J, Renner U, Zimmermann S, Kresse AE, Stalla GK, Keck ME, Holsboer F, Wurst W.

Expression of CRHR1 and CRHR2 in mouse pituitary and adrenal gland: Implications for HPA system

regulation. Endocrinology 2001;142(9):4150-3.

143. Lohrer P, Gloddek J, Hopfner U, Losa M, Uhl E, Pagotto U, Stalla GK, Renner U. Vascular endothelial

growth factor production and regulation in rodent and human pituitary tumor cells in vitro.


142. Pagotto U, Marsicano G, Fezza F, Theodoropoulou M, Grübler Y, Stalla J, Arzberger T, Milone A, Losa

M, Di Marzo V, Lutz B, Stalla GK. Normal human pituitary gland and pituitary adenomas express

cannabinoid receptor type 1 and synthesize endogenous cannabinoids: First evidence for a direct role of

cannabinoids on hormone modulation at the human pituitary level. J Clin Endocrinol Metab

2001;86(6):2687-96.

141. Perez Castro C, Carbia Nagashima A, Páez Pereda M, Goldberg V, Chervin A, Carrizo G, Molina H,

Renner U, Stalla GK, Arzt E. Effects of the gp130 cytokines ciliary neurotropic factor (CNTF) and

interleukin-11 on pituitary cells: CNTF receptors on human pituitary adenomas and stimulation of

prolactin and GH secretion in normal rat anterior pituitary aggregate cultures. J Endocrinol

2001;169(3):539-47.

140. Kuchenbauer F, Hopfner U, Stalla J, Arzt E, Stalla GK, Páez-Pereda M. Extracellular matrix components

regulate ACTH production and proliferation in corticotroph tumor cells. Mol Cell Endocrinol

2001;175(1-2):141-8.

139. Brunner J, Stalla GK, Stalla J, Uhr M, Grabner A, Wetter TC, Bronisch T. Decreased corticotropin-

releasing hormone (CRH) concentrations in the cerebrospinal fluid of eucortisolemic suicide attempters.

J Psychiatr Res 2001;35(1):1-9.

138. Arzt E, Kovalovsky D, Müller Igaz L, Costas M, Plazas P, Refojo D, Páez-Pereda M, Reul JMHM, Stalla

G, Holsboer F. Functional cross-talk among cytokines, T-cell receptor, and glucocorticoid receptor

transcriptional activity and action. Annals of the New York Academy of Sciences 2000;917:672-7.

137. Pagotto U, Arzberger T, Theodoropoulou M, Grübler Y, Pantaloni C, Saeger W, Losa M, Journot L,

Stalla GK, Spengler D. The expression of the antiproliferative gene ZAC is lost or highly reduced in

nonfunctioning pituitary adenomas. Cancer Res 2000;60(24):6794-9.

136. Castro CP, Nagashima AC, Pereda MP, Goldberg V, Chervin A, Largen P, Renner U, Stalla GK, Arzt E.

The gp130 cytokines interleukin-11 and ciliary neurotropic factor regulate through specific receptors the

function and growth of lactosomatotropic and folliculostellate pituitary cell lines. Endocrinology

2000;141(5):1746-53.

135. Pereda MP, Ledda MF, Goldberg V, Chervín A, Carrizo G, Molina H, Müller A, Renner U, Podhajcer O,

Arzt E, Stalla GK. High levels of matrix metalloproteinases regulate proliferation and hormone secretion

in pituitary cells. J Clin Endocrinol Metab 2000;85(1):263-9.

134. Lohrer P, Gloddek J, Carbia Nagashima A, Korali Z, Hopfner U, Paez Pereda M, Arzt E, Stalla GK,

Renner U. Lipopolysaccharide directly stimulates the intrapituitary interleukin-6 production by

folliculostellate cells via specific receptors and the p38α mitogen-activated protein kinase/nuclear factor-

κB pathway. Endocrinology 2000;141(12):4457-65.

133. Páez Pereda M, Missale C, Grübler Y, Arzt E, Schaaf L, Stalla GK. Nerve growth factor and retinoic acid

inhibit proliferation and invasion in thyroid tumor cells. Mol Cell Endocrinol 2000;167(1-2):99-106.

132. Schaaf L, Theodoropoulou M, Gregori A, Leiprecht A, Trojan J, Klostermeier J, Stalla GK. Thyrotropin-

releasing hormone time-dependently influences thyrotropin microheterogeneity - an in vivo study in

euthyroidism. J Endocrinol 2000;166(1):137-43.

131. Heuser I, Deuschle M, Weber B, Stalla GK, Holsboer F. Increased activity of the hypothalamus-

pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone.

Psychoneuroendocrinology 2000;25(5):513-8.

130. Páez Pereda M, Lohrer P, Kovalovsky D, Perez Castro C, Goldberg V, Losa M, Chervín A, Berner S,

Molina H, Stalla GK, Renner U, Arzt E. Interleukin-6 is inhibited by glucocorticoids and stimulates

ACTH secretion and POMC expression in human corticotroph pituitary adenomas. Experimental and


129. Antonijevic IA, Stalla GK, Steiger A. Modulation of the sleep electroencephalogram by estrogen

replacement in postmenopausal women. Obstet Gynecol 2000;182(2):277-82.

128. Friess E, Stalla G. Pregnenolone replacement. Tagliche Praxis 2000;41(4):832-3.

127. Theodoropoulou M, Arzberger T, Gruebler Y, Korali Z, Mortini P, Joba W, Heufelder AE, Stalla GK,

Schaaf L. Thyrotrophin receptor protein expression in normal and adenomatous human pituitary. J

Endocrinol 2000;167(1):7-13.

126. Stalla GK, Achaaf L. Endocrinology. Klinikarzt 1999;28(5):117.

125. Korali Z, Stalla GK. Pituitary adenomas. Klinikarzt 1999;28(5):119-24.

16

124. Páez Pereda M, Hopfner U, Pagotto U, Renner U, Uhl E, Arzt E, Missale C, Stalla GK. Retinoic acid

stimulates meningioma cell adhesion to the extracellular matrix and inhibits invasion. Br J Cancer

1999;81(3):381-6.

123. Korali Z, Stalla GK. Hormone level out plumb. how to detect and treat pituitary gland tumors? Arztliche

Praxis Neurologie Psychiatrie 1999(9):28-31.

122. Kovalovsky D, Pereda MP, Stalla GK, Holsboer F, Arzt E. Differential regulation of interleukin-1

receptor antagonist by proopiomelanocortin peptides adrenocorticotropic hormone and β-endorphin.

Neuroimmunomodulation 1999;6(5):367-72.

121. Oefelein W, Stalla GK. Transsexuality - finding the right sex with medical support. Fortschr Med

1999;117(23):31.

120. Schlatterer K, Bronisch T, Stalla GK. Transsexualism - A multidisciplinary problem. Fortschr Med

1999;117(23):32-6.

119. Stalla GK. Transsexualism--medical intervention can lead to correct gender. MMW Fortschr Med

1999;141(23):31.

118. Schlatterer VK, Bronisch T, Stalla GK. Transsexualität - eine multidisziplinäre problematik: Welche

therapieansätze haben sich als tauglich erwiesen? Munch Med Wochenschr 1999;141(23):32-6.

117. Newton CJ, Drummond N, Burgoyne CH, Speirs V, Stalla GK, Atkin SL. Functional inactivation of the

oestrogen receptor by the antioestrogen, ZM 182780, sensitises tumour cells to reactive oxygen species. J

Endocrinol 1999;161(2):199-210.

116. Gloddek J, Pagotto U, Paez Pereda M, Arzt E, Stalla GK, Renner U. Pituitary adenylate cyclase-

activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial

growth factor in pituitary folliculostellate cells. J Endocrinol 1999;160(3):483-90.

115. Pagotto U, Arzberger T, Ciani E, Lezoualc'h F, Pilon C, Journot L, Spengler D, Stalla GK. Inhibition of

Zac1, a new gene differentially expressed in the anterior pituitary, increases cell proliferation.

Endocrinology 1999;140(2):987-96.

114. Castro CP, Peñalva R, Pereda MP, Renner U, Reul JMHM, Stalla GK, Holsboer F, Arzt E. Early

activation of thyrotropin-releasing-hormone and prolactin plays a critical role during a T cell-dependent

immune response. Endocrinology 1999;140(2):690-7.

113. Arzt E, Pereda MP, Castro CP, Pagotto U, Renner U, Stalla GK. Pathophysiological role of the cytokine

network in the anterior pituitary gland. Front Neuroendocrinol 1999;20(1):71-95.

112. Sauer J, Renner U, Hopfner U, Lange M, Müller A, Strasburger CJ, Pagotto U, Arzt E, Stalla GK.

Interleukin-1β enhances interleukin-1 receptor antagonist content in human somatotroph adenoma cell

cultures. J Clin Endocrinol Metab 1998;83(7):2429-34.

111. Renner U, Arzberger T, Pagotto U, Leimgruber S, Uhl E, Müller A, Lange M, Weindl A, Stalla GK.

Heterogenous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically

nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 1998;83(4):1368-75.

110. Frieboes R-, Murck H, Stalla GK, Antonijevic IA, Steiger A. Enhanced slow wave sleep in patients with

prolactinoma. J Clin Endocrinol Metab 1998;83(8):2706-10.

109. Schlatterer K, Yassouridis A, Von Werder K, Poland D, Kemper J, Stalla GK. A follow-up study for

estimating the effectiveness of a cross-gender hormone substitution therapy on transsexual patients. Arch

Sex Behav 1998;27(5):475-92.

108. Schlatterer K, Auer DP, Yassouridis A, Von Werder K, Stalla GK. Transsexualism and osteoporosis.


107. Trojan J, Theodoropoulou M, Usadel KH, Stalla GK, Schaaf L. Modulation of human thyrotropin

oligosaccharide structures - enhanced proportion of sialylated and terminally galactosylated serum

thyrotropin isoforms in subclinical and overt primary hypothyroidism. J Endocrinol 1998;158(3):359-65.

106. Renner U, Gloddek J, Pereda MP, Arzt E, Stalla GK. Regulation and role of intrapituitary IL-6

production by folliculostellate cells. Domest Anim Endocrinol 1998;15(5):353-62.

105. Kovalovsky D, Pereda MP, Sauer J, Castro CP, Nahmod VE, Stalla GK, Holsboer F, Arzt E. The Th1

and Th2 cytokines IFN-γ and IL-4 antagonize the inhibition of monocyte IL-1 receptor antagonist by

glucocorticoids: Involvement of IL-1. Eur J Immunol 1998;28(7):2075-85.

104. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JMHM, Stalla GK, Blanquet V, Steckler T, Holsboer F,

Wurst W. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-

releasing hormone receptor 1. Nat Genet 1998;19(2):162-6.

103. Arzt E, Páez Pereda M, Costas M, Sauer J, Renner U, Holsboer F, Stalla GK. Cytokine expression and

molecular mechanisms of their auto/paracrine regulation of anterior pituitary function and growth.

Annals of the New York Academy of Sciences 1998;840:525-31.

102. Schaaf L, Pickel J, Hoppner W, Stalla GK. Report of 91 multiple endocrine neoplasia type 1 patients in

germany. Experimental and Clinical Endocrinology and Diabetes 1998;106(1):A9-A10.

17

101. Oefelein W, Pickel J, Miedl I, Schaaf L, Stalla GK. A concept for the growth hormone substitution of

growth hormone deficient adults: An open study with 50 patients. Experimental and Clinical

Endocrinology and Diabetes 1998;106(1):A18-9.

100. Zetzsche T, Probst C, Stalla GK. Trefoil polypeptides in pituitary adenomas: Coexistence with

proliferating cell nuclear antigen (PCNA) and estrogenreceptor. Experimental and Clinical

Endocrinology and Diabetes 1998;106(1):A20-1.

99. Renner U, Gloddek J, Arzt E, Stalla GK. Regulation of the intrapituitary IL-6 production in response to

LPS and glucocorticoids: A novel route of immune-endocrine cross talk. Experimental and Clinical

Endocrinology and Diabetes 1998;106(1).

98. Oefelein W, Hensen J, Ventz M, Stalla GK. Octreotide has an analgesic effect in acromegalic patients

with chronic headache: Experience with 4 patients. Experimental and Clinical Endocrinology and

Diabetes 1998;106(1).

97. Pagotto U, Paez Pereda M, Renner U, Stalla GK. New aspects in pituitary tumor pathogenesis.

Experimental and Clinical Endocrinology and Diabetes 1998;106(1).

96. Renner U, Gloddek J, Arzt E, Inoue K, Stalla GK. Interleukin-6 is an autocrine growth factor for

folliculostellate-like TtT/GF mouse pituitary tumor cells. Experimental and Clinical Endocrinology and

Diabetes 1997;105(6):345-52.

95. Chen B-, Stalla VBSGE, Jan R. 1H NMR study of interaction of cis-[pt(NH3)2(4-methylpyridine)cl]NO3

with 5-methylglutathione. Kao Teng Hsueh Hsiao Hua Heush Hsueh Pao/ Chemical Journal of Chinese

Universities 1997;18(6):x3-845.

94. Karanth S, Linthorst ACE, Stalla GK, Barden N, Holsboer F, Reul JMHM. Hypothalamic-pituitary-

adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function.

Endocrinology 1997;138(8):3476-85.

93. Pereda MP, Castro CP, Costas M, Nahmod VE, Stalla GK, Holsboer F, Arzt E. Glucocorticoids inhibit

the autoregulatory induction of interleukin-1 in monocytes after endotoxin stimulation.


92. Schlatterer K, Von Werder K, Stalla GK. Multistep treatment concept of transsexual patients.


91. Von Werder K, Muller OA, Stalla GK. Somatostatin analogs in ectopic corticotropin production.

Metabolism: Clinical and Experimental 1996;45(SUPPL.1):129-31.

90. Páez Pereda M, Goldberg V, Chervín A, Carrizo G, Molina A, Andrada J, Sauer J, Renner U, Stalla GK,

Arzt E. Interleukin-2 (IL-2) and IL-6 regulate c-fos protooncogene expression in human pituitary

adenoma explants. Mol Cell Endocrinol 1996;124(1-2):33-42.

89. Renner U, Pagotto U, Arzt E, Stalla GK. Autocrine and paracrine roles of polypeptide growth factors,

cytokines and vasogenic substances in normal and tumorous pituitary function and growth: A review.


88. Riepl RL, Reichardt B, Auernhammer CJ, Beier G, Schopohl J, Stalla GK, Lehnert P. Suppression of

vagus-mediated pancreatic polypeptide release by the μ-opiate receptor agonist loperamide in man. Br J

Clin Pharmacol 1996;42(3):371-7.

87. Arzt E, Stalla GK. Cytokines: Autocrine and paracrine roles in the anterior pituitary.


86. Sauer J, Castren M, Hopfner U, Holsboer F, Stalla GK, Arzt E. Inhibition of lipopolysaccharide-induced

monocyte interleukin-1 receptor antagonist synthesis by cortisol: Involvement of the mineralocorticoid

receptor. J Clin Endocrinol Metab 1996;81(1):73-9.

85. Pereda MP, Sauer J, Castro CP, Finkielman S, Stalla GK, Holsboer F, Arzt E. Corticotropin-releasing

hormone differentially modulates the interleukin-1 system according to the level of monocyte activation

by endotoxin. Endocrinology 1995;136(12):5504-10.

84. Sauer J, Polack E, Wikinski S, Holsboer F, Stalla GK, Arzt E. The glucocorticoid sensitivity of

lymphocytes changes according to the activity of the hypothalamic-pituitary-adrenocortical system.


83. Pagotto U, Arzberger T, Hopfner U, Sauer J, Renner U, Newton CJ, Lange M, Uhl E, Weindl A, Stalla

GK. Expression and localization of endothelin-1 and endothelin receptors in human meningiomas:

Evidence for a role in tumoral growth. J Clin Invest 1995;96(4):2017-25.

82. Arzt E, Sauer J, Buric R, Stalla J, Renner U, Stalla GK. Characterization of interleukin-2 (IL-2) receptor

expression and action of IL-2 and IL-6 on normal anterior pituitary cell growth. Endocrine

1995;3(2):113-9.

81. Pagotto U, Arzberger T, Hopfner U, Weindl A, Stalla GK. Cellular localization of endothelin receptor

mRNAs (ET(A) and ET(B)) in brain tumors and normal human brain. J Cardiovasc Pharmacol

1995;26(SUPPL. 3):S104-6.

18

80. Renner U, Newton CJ, Pagotto U, Sauer J, Arzt E, Stalla GK. Involvement of interleukin-1 and

interleukin-1 receptor antagonist in rat pituitary cell growth regulation. Endocrinology

1995;136(8):3186-93.

79. Lange M, Pagotto U, Hopfner U, Ehrenreich H, Oeckler R, Sinowatz F, Stalla GK. Endothelin expression

in normal human anterior pituitaries and pituitary adenomas. J Clin Endocrinol Metab 1994;79(6):1864-

70.

78. Sauer J, Arzt E, Gumprecht H, Hopfner U, Stalla GK. Expression of interleukin-1 receptor antagonist in

human pituitary adenomas in vitro. J Clin Endocrinol Metab 1994;79(6):1857-63.

77. Newton CJ, Arzt E, Stalla GK. Involvement of the estrogen receptor in the growth response of pituitary

tumor cells to interleukin-2. Biochem Biophys Res Commun 1994;205(3):1930-7.

76. Newton CJ, Trapp T, Pagotto U, Renner U, Buric R, Stalla GK. The oestrogen receptor modulates

growth of pituitiary tumour cells in the absence of exogenous oestrogen. J Mol Endocrinol

1994;12(3):303-12.

75. Renner U, Brockmeier S, Strasburger CJ, Lange M, Schopohl J, Müller OA, Werder KV, Stalla GK.

Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma

cells: Interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide. J Clin

Endocrinol Metab 1994;78(5):1090-6.

74. Renner U, Mojto J, Lange M, Muller OA, Von Werder K, Stalla GK. Effect of bromocriptine and SMS

201-995 on growth of human somatotrophic and non-functioning pituitary adenoma cells in vitro.


73. Stalla GK, Brockmeier SJ, Renner U, Newton C, Buchfelder M, Stalla J, Muller OA. Octreotide exerts

different effects in vivo and in vitro in cushing's disease. European Journal of Endocrinology

1994;130(2):125-31.

72. Arzt E, Sauer J, Pollmächer T, Labeur M, Holsboer F, Reul JMHM, Stalla GK. Glucocorticoids suppress

interleukin-1 receptor antagonist synthesis following induction by endotoxin. Endocrinology

1994;134(2):672-7.

71. Newton CJ, Buric R, Trapp T, Brockmeier S, Pagotto U, Stalla GK. The unliganded estrogen receptor

(ER) transduces growth factor signals. J Steroid Biochem Mol Biol 1994;48(5-6):481-6.

70. Auernhammer CJ, Riepl RL, Schopohl J, Lehnert P, Muller OA, Stalla GK. In man the mu-opiate agonist

loperamide specifically inhibits ACTH secretion induced by the cholecystokinin-like peptide ceruletide.


69. Sauer J, Stalla GK, Muller O-, Arzt E. Inhibition of interleukin-2-mediated lymphocyte activation in

patients with cushing's syndrome: A comparison with hypocortisolemic patients. Neuroendocrinology

1994;59(2):144-51.

68. Buchfelder M, Fahlbusch R, Wentzlaff-Eggebert H, Brabant G, Stalla GK, Müller OA. Does an analysis

of the pulsatile secretion pattern of adrenocorticotropin and cortisol predict the result of transsphenoidal

surgery in cushing's disease? J Clin Endocrinol Metab 1993;77(3):720-4.

67. Sauer J, Rupprecht M, Arzt E, Stalla GK, Rupprecht R. Glucocorticoids modulate soluble interleukin-2

receptor levels in vivo depending on the state of immune activation and the duration of glucocorticoid

exposure. Immunopharmacology 1993;25(3):269-76.

66. Auernhammer CJ, Renner U, Muller O-, Stalla J, Stalla GK. Loperamide inhibits corticotrophic cell

function by a naloxone-insensitive mechanism in the rat in vitro. Neuroendocrinology 1993;57(6):1019-

27.

65. Puchner MJA, Ludecke DK, Valdueza JM, Saeger W, Willig RP, Stalla GK, Odink RJ, Oyesiku NM,

Tindall GT, Kovacs KT. Cushing's disease in a child caused by a corticotropin-releasing hormone-

secreting intrasellar gangliocytoma associated with an adrenocorticotropic hormone-secreting pituitary

adenoma. Neurosurgery 1993;33(5):920-5.

64. Arzt E, Buric R, Stelzer G, Stalla J, Sauer J, Renner U, Stalla GK. Interleukin involvement in anterior

pituitary cell growth regulation: Effects of IL-2 and IL-6. Endocrinology 1993;132(1):459-67.

63. Renner U, Mojto J, Arzt E, Lange M, Stalla J, Muller O-, Stalla GK. Secretion of polypeptide growth

factors by human nonfunctioning pituitary adenoma cells in culture. Neuroendocrinology

1993;57(5):825-34.

62. Arzt E, Stelzer G, Renner U, Lange M, Müller OA, Stalla GK. Interleukin-2 and interleukin-2 receptor

expression in human corticotrophic adenoma and murine pituitary cell cultures. J Clin Invest

1992;90(5):1944-51.

61. Auernhammer CJ, Stalla GK, Lange M, Pfeiffer A, Müller OA. Effects of loperamide on the human

hypothalamo-pituitary-adrenal axis in vivo and in vitro. J Clin Endocrinol Metab 1992;75(2):552-7.

60. Hoops JP, Stalla GK, Mojto J, Renner U, Bauer S, Stalla J, Müller OA. 017 enrichment of rat

corticotrophic cells by centrifugation on a continuous percoll density gradient: Are there corticotrophic

subpopulations? Fresenius J Anal Chem 1992;343(1):68-9.

19

59. Muller OA, Stalla GK. Drug therapy of cushing's syndrome. Aktuelle Endokrinologie Und Stoffwechsel

1990;11(1):27-34.

58. Nikolarakis KE, Pfeiffer A, Stalla GK, Herz A. Facilitation of ACTH secretion by morphine is mediated

by activation of CRF releasing neurons and sympathetic neuronal pathways. Brain Res 1989;498(2):385-

8.

57. Stalla GK, Bost H, Stalk J, Kaliebe T, Dörr HG, Pfeiffer D, Werder KV, Müller OA. Human

corticotropin-releasing hormone during pregnancy. Gynecological Endocrinology 1989;3(1):1-10.

56. Stalla GK, Stalla J, Von Werder K, Muller OA, Gerzer R, Hollt V, Jakobs KH. Nitroimidazole

derivatives inhibit anterior pituitary cell function apparently by a direct effect on the catalytic subunit of

the adenylate cyclase holoenzyme. Endocrinology 1989;125(2):699-706.

55. Von Bardeleben U, Wiedemann K, Stalla GK, Müller OA, Holsboer F. Exaggerated corticotrophic cell

response to human corticotropin-releasing hormone in two patients during long-term carbamazepine

treatment. Biol Psychiatry 1988;24(3):331-5.

54. Schreiber W, Krieg J-, Bossert S, Junker M, Rauschhuber R, Stalla GK, Müller OA, Berger M.

Methodological aspects of hCRF-stimulated ACTH and cortisol secretion in healthy subjects.


53. Bieling W, Stalla GK, Stalla J, Müller OA. Direct ACTH measurement in plasma: Comparison of 6

commercially available kits with a RIA after prior extraction and an IRMA. Fresenius' Zeitschrift Für

Analytische Chemie 1988;330(4-5):401-2.

52. Bardeleben Uv, Stalla GK, Müller OA, Holsboer F. Blunting of ACTH response to human CRH in

depressed patients is avoided by metyrapone pretreatment. Biol Psychiatry 1988;24(7):782-6.

51. Stalla GK, Losa M, Oeckler R, Muller OA, Von Werder K. Insulin hypoglycemia test and releasing

hormone (corticotropin-releasing hormone and growth hormone-releasing hormone) stimulation in

patients with pituitary failure of different origin. Horm Res 1988;29(5-6):191-6.

50. Holsboer F, Stalla GK, von Bardeleben U, Hammann K, Müller H, Müller OA. Acute adrenocortical

stimulation by recombinant gamma interferon in human controls. Life Sci 1988;42(1):1-5.

49. Stalla GK, Stalla J, Huber M, Loeffler J-, Hollt V, Von Werder K, Muller OA. Ketoconazole inhibits

corticotropic cell function in vitro. Endocrinology 1988;122(2):618-23.

48. Schrell U, Fahlbusch R, Buchfelder M, Riedl S, Stalla GK, Muller OA. CRH test after pituitary

microsurgery suggests tertiary adrenocortical insufficiency in successful operated patients with cushing's

disease. Hormone and Metabolic Research 1987;19(SUPPL. 16):64-5.

47. Muller OA, Stalla GK, Von Werder K. CRH in cushing's syndrome. Hormone and Metabolic Research

1987;19(SUPPL. 16):51-8.

46. Stalla GK, Stalla J, Loeffler JP, Von Werder K, Muller OA. Pharmacological modulation of CRH-

stimulated ACTH secretion by ketokonazole. Hormone and Metabolic Research 1987;19(SUPPL. 16):31-

6.

45. Nikolarakis K, Pfeiffer A, Stalla GK, Herz A. The role of CRF in the release of ACTH by opiate agonists

and antagonists in rats. Brain Res 1987;421(1-2):373-6.

44. Schrell U, Fahlbusch R, Buchfelder M, Riedl S, Stalla GK, Müller OA. Corticotropin-releasing hormone

stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with

cushing's disease. J Clin Endocrinol Metab 1987;64(6):1150-9.

43. Stalla GK, Stalla J, von Werder K, Müller OA, Lüdecke DK, Schrell U, Fahlbusch R. Corticotropin

releasing hormone in plasma of patients with cushing's disease. Klin Wochenschr 1987;65(11):529.

42. Muller OA, Stalla GK, Von Werder K. Corticotropin-releasing factor in humans. II. CRF stimulation in

patients with diseases of the hypothalamo-pituitary-adrenal axis. Horm Res 1987;25(4):185-98.

41. Holsboer F, Gerken A, Stalla GK, Muller OA. Blunted aldosterone and ACTH release after human CRH

administration in depressed patients. Am J Psychiatry 1987;144(2):229-31.

40. Holsboer F, von Bardeleben U, Wiedemann K, Müller OA, Stalla GK. Serial assessment of corticotropin-

releasing hormone response after dexamethasone in depression implications for pathophysiology of DST

nonsuppression. Biol Psychiatry 1987;22(2):228-34.

39. Stalla GK, Stalla J, Schopohl J, von Werder K, Müller OA. Corticotropin-releasing factor in humans. I.

CRF stimulation in normals and CRF radioimmunoassay. Horm Res 1986;24(4):229-45.

38. Schopohl J, Hauer A, Kaliebe T, Stalla GK, von Werder K, Müller OA. Repetitive and continuous

administration of human corticotropin releasing factor to human subjects. Acta Endocrinol

1986;112(2):157-65.

37. Stalla GK, Hartwimmer J, Schopohl J, von Werder K, Müller OA. Intravenous application of ovine and

human corticotropin releasing factor (CRF): ACTH, cortisol and CRF levels. Neuroendocrinology

1986;42(1):1-5.

36. Holsboer F, Gerken A, von Bardeleben U, Grimm W, Beyer H, Müller OA, Stalla GK. Human

corticotropin-releasing hormone in depression-correlation with thyrotropin secretion following

thyrotropin-releasing hormone. Biol Psychiatry 1986;21(7):601-11.

20

35. Schopohl J, Losa M, König A, Müller OA, Stalla GK, von Werder K. Combined pituitary function-test

with four hypothalamic releasing hormones. Klin Wochenschr 1986;64(7):314-8.

34. Stalla GK, Stalla J, Müller OA. Serum dehydroepiandrosterone sulphate (DS): Radioimmunoassay and

DS-levels in normals and patients. Fresenius' Zeitschrift Für Analytische Chemie 1986;324(3-4):259.

33. Laakmann G, Wittmann M, Schoen HW, Zygan K, Weiss A, Meissner R, Mueller OA, Stalla GK.

Effects of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on

desimipramine-induced pituitary hormone stimulation in humans-III. hypothalamo-pituitary-

adrenocortical axis. Psychoneuroendocrinology 1986;11(4):475-89.

32. Müller OA, Hartwimmer J, Hauer A, Kaliebe T, Schopohl J, Stalla GK, von Werder K. Corticotropin-

releasing factor (CRF): Stimulation in normal controls and in patients with cushing's syndrome.


31. Moore CA, Stalla GK, Müller OA. Value of a saliva cortisol radioimmunoassay in the testing of the

hypothalamic-pituitary-adrenal axis. Fresenius' Zeitschrift Für Analytische Chemie 1986;324(3-4):260.

30. Werder KV, Losa M, Stalla GK, Müller OA, Mayr B, Schweiberer L, Fahlbusch R. Long-term treatment

of a metastasizing GRFoma with a somatostatin analogue (SMS 201-995) in a girl with gigantism. Scand

J Gastroenterol 1986;21(S119):238-42.

29. Stalla GK, Doerr HG, Bidlingmaier F, Sippel WG, von Restorff W. Serum levels of eleven steroid

hormones following motion sickness. Aviation Space and Environmental Medicine 1985;56(10):995-9.

28. Losa M, Schopohl J, Stalla GK, Müller OA, von Werder K. Growth hormone releasing factor-test in

acromegaly: Comparison with other dynamic tests. Clin Endocrinol (Oxf) 1985;23(2):99-109.

27. von Bardeleben U, Holsboer F, Stalla GK, Müller OA. Combined administration of human corticotropin-

releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in

healthy subjects. Life Sci 1985;37(17):1613-8.

26. Holsboer F, Gerken A, Von Bardeleben U, Grimm W, Stalla GK, Müller OA. Relationship between

pituitary responses to human corticotropin-releasing factor and thyrotropin-releasing hormone in

depressives and normal controls. Eur J Pharmacol 1985;110(1):153-4.

25. von Werder K, Losa M, Stalla GK, Bock L, Müller OA. Human pancreatic growth hormone releasing

factor (hpGRF): GRF-and GH-levels after bolus injection and infusion of hpGRF1-44. Acta Neurochir

1985;75(1-4):81-7.

24. Müller OA, Stalla GK, Hartwimmer J, Schopohl J, von Werder K. Corticotropin releasing factor (CRF):

Diagnostic implications. Acta Neurochir 1985;75(1-4):49-59.

23. Berger M, Pirke KM, Krieg CJ, von Zerssen D, Muller OA, Stalla GK. ACTH and cortisol levels in

healthy probands and psychiatric patients following the dexamethasone suppression test. Am J Psychiatry

1985;142(2):268-9.

22. Holsboer F, Gerken A, Stalla GK, Müller OA. ACTH, cortisol, and corticosterone output after ovine

corticotropin-releasing factor challenge during depression and after recovery. Biol Psychiatry

1985;20(3):276-86.

21. Muller OA, Stalla GK, Von Werder K. Corticotropin releasing factor: Diagnostic aspects. Internist

1985;26(5):251-8.

20. Holsboer F, von Bardeleben U, Gerken A, Stalla GK, Müller OA. Blunted corticotropin and normal

cortisol response to human corticotropin-releasing factor in depression. N Engl J Med

1984;311(17):1127.

19. Holsboer F, Müller OA, Doerr HG, Sippell WG, Stalla GK, Gerken A, Steiger A, Boll E, Benkert O.

ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: Relationship to

multisteroid responses after ACTH stimulation and dexamethasone suppression.


18. Losa M, Bock L, Schopohl J, Stalla GK, Müller OA, von Werder K. Growth hormone releasing factor

infusion does not sustain elevated GH-levels in normal subjects. Acta Endocrinol 1984;107(4):462-70.

17. Laakmann G, Wittmann M, Gugath M, Mueller OA, Treusch J, Wahlster U, Stalla GK. Effects of

psychotropic drugs (desimipramine, chlorimipramine, sulpiride and diazepam) on the human HPA axis.

Psychopharmacology (Berl ) 1984;84(1):66-70.

16. Stalla GK, Hartwimmer J, Von Werder K, Muller OA. Ovine (o) and human (h) corticotrophin releasing

factor (CRF) in man: CRF-stimulation and CRF-immunoreactivity. Acta Endocrinol 1984;106(3):289-97.

15. Stalla GK, Hartwimmer J, Böck M, Müller OA. Human sex hormone binding globulin (SHBG):

Isolation, characterization and determination. Fresenius' Zeitschrift Für Analytische Chemie

1984;317(6):732.

14. Hörl A, Stalla GK, Hartwimmer J, Müller OA. Direct measurement of β-endorphin in human plasma.

Fresenius' Zeitschrift Für Analytische Chemie 1984;317(6):729-30.

13. Baumeister M, Stalla GK, Müller OA. Problems in quantitative analysis of five steroid hormones by

HPLC. Fresenius' Zeitschrift Für Analytische Chemie 1984;317(6):683-4.

21

12. Losa M, Stalla GK, Muller OA, Von Werder K. Human pancreatic growth hormone-releasing factor

(hpGFR): Dose-response of GRF- and GH-levels. Klin Wochenschr 1983;61(24):1249-53.

11. Muller OA, Stalla GK, Von Werder K. Corticotropin releasing factor: A new tool for the differential

diagnosis of cushing's syndrome. J Clin Endocrinol Metab 1983;57(1):227-9.

10. Muller OA, Hagen B, Stalla GK, Von Werder K. CRF stimulation test for the diagnosis of hypothalamo

pituitary diseases. Acta Endocrinologica, Supplement 1983;102(253):86-7.

9. Müller OA, Dörr HG, Hagen B, Stalla GK, v. Werder K. Corticotropin releasing factor (CRF)-

stimulation test in normal controls and patients with disturbances of the hypothalamo-pituitary-adrenal

axis. Klin Wochenschr 1982;60(24):1485-91.

8. Stalla GK, Dorr HG, Eisele G. Effect of ACTH, GH, and PRL on in vitro and in vivo steroidogenesis of

the rabbit. Acta Endocrinologica, Supplement 1982;99(Suppl. 246).

7. Stalla GK, Krassnigg F, Müller OA. Purification of sex hormone binding globulin (SHBG) from human

serum. Fresenius' Zeitschrift Für Analytische Chemie 1982;311(4):458-9.

6. Krassnigg S, Rjosk HK, Stalla GK, Von Werder K. Relaxin: Radioimmunoassay and extraction from

human placenta. Acta Endocrinologica, Supplement 1982;99(Suppl. 246).

5. Stalla GK, Giesemann G, Müller OA, Wood WG, Scriba PC. The development of a direct homologous

radioimmunoassay for serum cortisol. Journal of Clinical Chemistry and Clinical Biochemistry

1981;19(7):427-34.

4. Stalla G, Giesemann G, Müller OA, Wood WG, Scriba PC. Non-extractive and specific

radioimmunoassay for cortisol: Results using a pure cortisol-C3-derivative for antigen and tracer

production. Fresenius' Zeitschrift Für Analytische Chemie 1980;301(2):129.

3. Wood WG, Mueller OA, Stalla G, Scriba PC. Improvement of the calcitonin radioimmunoassay. Journal

of Clinical Chemistry and Clinical Biochemistry 1979;17(12):781-7.

2. Wood WG, Stalla G, Mueller OA, Scriba PC. A rapid and specific method for separation of bound and

free antigen in radioimmunoassay systems. Journal of Clinical Chemistry and Clinical Biochemistry

1979;17(3):111-4.

1. Stalla G, Müller OA, Wood WG, Scriba PC. Problems in automation of serum cortisol

radioimmunoassay. Fresenius' Zeitschrift Für Analytische Chemie 1978;290(2):168-9.

Date post:	13-Sep-2018
Category:	Documents
Upload:	hoangtram
View:	215 times
Download:	0 times

Bibliography of Prof. Dr. med. Günter K. Stalla · 423. Boeckel JN, Palapies L, Klotsche J, Zeller...

Documents